About

Introduction

Statistics

VIOLIN News

Your VIOLIN

Register or Login

Submission

Tutorial

Vaccine & Components

Vaxquery

Vaxgen

VBLAST

Protegen

VirmugenDB

DNAVaxDB

CanVaxKB

Vaxjo

Vaxvec

Vevax

Huvax

Cov19VaxKB

Host Responses

VaximmutorDB

VIGET

Vaxafe

Vaxar

Vaxism

Vaccine Literature

VO-SciMiner

Litesearch

Vaxmesh

Vaxlert

Vaccine Design

Vaxign2

Vaxign

Community Efforts

Vaccine Ontology

ICoVax 2012

ICoVax 2013

Advisory Committee

Vaccine Society

Vaxperts

VaxPub

VaxCom

VaxLaw

VaxMedia

VaxMeet

VaxFund

VaxCareer

Data Exchange

V-Utilities

VIOLINML

Help & Documents

Publications

Documents

FAQs

Links

Acknowledgements

Disclaimer

Contact Us

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Nov 01, 2024 To Nov 21, 2024:

---

Bacillus anthracis (Anthrax)

1. Ashique S, Biswas A, Mohanto S, Srivastava S, Hussain MS, Ahmed MG, Subramaniyan V. Anthrax: A narrative review New microbes and new infections 62:101501 2024 [PMID: 39497912]
2. Rani S, Ramesh V, Khatoon M, Shijili M, Archana CA, Anand J, Sagar N, Sekar YS, Patil AV, Palavesam A, Barman NN, Patil SS, Hemadri D, Suresh KP. Identification of molecular and cellular infection response biomarkers associated with anthrax infection through comparative analysis of gene expression data Computers in biology and medicine 184:109431 2024 [PMID: 39556915]
3. Arede M, Allepuz A, Beltran-Alcrudo D, Casal J, Romero-Alvarez D. Suitability of anthrax (Bacillus anthracis) in the Black Sea basin through the scope of distribution modelling PloS one 19(11):e0303413 2024 [PMID: 39509442]
4. Ghosal S, Pradhan R, Singh S, Velayudhan A, Kerketta S, Parai D, Choudhary HR, Pattnaik M, Bhattacharya D, Pati S. One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review The Lancet regional health. Southeast Asia 30:100503 2024 [PMID: 39507524]

Brucella (Brucellosis)

1. Yang J, Liu X, Yang H, Wang H, Xie B, Gao W, Xu M, Xu X, Liu B, Chen Z. Combination application of Pickering emulsion and BLS protein nanoparticles enhances vaccine efficacy International journal of biological macromolecules 283(Pt 2):137635 2024 [PMID: 39547601]
2. Ta N, Zuo KM, Gao J, Guan N, Song LT, Wen YJ, Yu RP. Origin tracking of Brucella strain B. melitensis bv.3 ARQ-070 using biochemical and genomic studies FEMS microbiology letters 2024 [PMID: 39537199]
3. Esmaeili H, Ghorani M, Hamidiya Z, Joghataei SM, Villanueva-Saz S, Lacasta D. Causes of abortion in Iranian goat herds and associated risk factors Preventive veterinary medicine 234:106381 2024 [PMID: 39536431]
4. Habibi G, Mehrabadi MHF, Fathi S, Esmaeilnia K, Shahedi A, Yazdani F, Afshari A. Detection of Babesia spp., and Theileria spp., in sheep across diverse provinces of Iran Veterinary parasitology, regional studies and reports 56:101131 2024 [PMID: 39550187]
5. Ghosal S, Pradhan R, Singh S, Velayudhan A, Kerketta S, Parai D, Choudhary HR, Pattnaik M, Bhattacharya D, Pati S. One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review The Lancet regional health. Southeast Asia 30:100503 2024 [PMID: 39507524]
6. Sadooghi N, Alamian S, Ghasemzadeh Moghadam H, Yazdanmanesh M, Dadar M. Serological and bacterial prevalence of Brucella spp. in suspected patients: a risk factor analysis in North Khorasan, Iran Iranian journal of microbiology 16(5):639-647 2024 [PMID: 39534295]

Burkholderia mallei (Glanders)

1. Pooja, Thapa N, Rani R, Shanmugasundaram K, Jhandai P, Rakshita, Bhattacharya TK, Singha H. Antibody isotyping and cytokine profiling in natural cases of Burkholderia mallei infection (glanders) in equines Cytokine 185:156799 2024 [PMID: 39549470]

Clostridium perfringens

1. Nakhaipour E, Alimolaei M, Kariminik A, Bafti MS. Bioinformatic Analysis of the Structural Features of the H106P/N137A Mutant as a Potential Vaccine Candidate Against Clostridium perfringens Clinical laboratory 70(11) 2024 [PMID: 39506593]

Coronavirus

1. Braverman G, Barbhaiya M, Nong M, Mandl LA. Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review Rheumatic diseases clinics of North America 51(1):75-92 2025 [PMID: 39550108]
2. Ezeh N, Boadi T, Danila MI, Ramsey-Goldman R, Feldman CH. Interventions to Improve COVID-19 Vaccine Hesitancy Rheumatic diseases clinics of North America 51(1):61-73 2025 [PMID: 39550107]
3. Ammitzbøll C, Thomsen MK, Erikstrup C, Troldborg A. Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients Rheumatic diseases clinics of North America 51(1):45-59 2025 [PMID: 39550106]
4. Waghmare A, Hijano DR. SARS-CoV-2 Infection and COVID-19 in Children Rheumatic diseases clinics of North America 51(1):139-156 2025 [PMID: 39550102]
5. Bertini CD Jr, Khawaja F, Sheshadri A. Coronavirus Disease-2019 in the Immunocompromised Host Rheumatic diseases clinics of North America 51(1):123-138 2025 [PMID: 39550101]
6. Pozdnyakova V, Weber B, Cheng S, Ebinger JE. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination Rheumatic diseases clinics of North America 51(1):111-121 2025 [PMID: 39550100]
7. Kohn SO, Jagadish I, McNaughton J, Young KJ. The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases Rheumatic diseases clinics of North America 51(1):1-13 2025 [PMID: 39550099]
8. Lee A, Davido B, Beck E, Demont C, Joshi K, Kohli M, Maschio M, Uhart M, El Mouaddin N. Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France Human vaccines & immunotherapeutics 20(1):2423474 2024 [PMID: 39540209]
9. Elhassan Taha MM, Abdelwahab SI, Moni SS, Farasani A, Aljahdali IA, Oraibi B, Alfaifi HA, Alzahrani AH, Ali Jerah A. Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research Human vaccines & immunotherapeutics 20(1):2427464 2024 [PMID: 39539151]
10. Zhang SS, Shi W, Du J, Zhang WX, Yuan M, Zhou Y, Wang L, Zhao T, Ma QY, Zhang S, Yang H, Zhang X, Wang M, Huang N, Zeng J, Liu Y, Zhang Y, Cui F, Lu QB. Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China Human vaccines & immunotherapeutics 20(1):2428017 2024 [PMID: 39539085]
11. Yu MKL, Chan SHS, Leung D, Cheng S, Tsang LCH, Kwan TC, Zhang K, Wang X, Tu W, Peiris M, Lau YL, Rosa Duque JS. Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients Human vaccines & immunotherapeutics 20(1):2424615 2024 [PMID: 39539036]
12. Guillaume AS, Ndwandwe D, Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Tamuzi JL, Iwu-Jaja C, Shindano TA, Wiysonge CS, Katoto PDMC. Caregivers' hesitancy and outright refusal toward children's COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study Human vaccines & immunotherapeutics 20(1):2422686 2024 [PMID: 39535129]
13. Chen C, Tang T, Chen Z, Chen L, Cheng J, Li F, Sun J, Zhao J, Wang Y, Yan Q, Zhao J, Zhu A. Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines Human vaccines & immunotherapeutics 20(1):2423466 2024 [PMID: 39535117]
14. Wu JS, Huang KK. Measuring influencing factors affecting mortality rates during the COVID-19 pandemic Global health action 17(1):2428067 2024 [PMID: 39530400]
15. Alshagrawi S. Impact of COVID-19 pandemic on influenza vaccination rate among health care workers Human vaccines & immunotherapeutics 20(1):2426284 2024 [PMID: 39523588]
16. Fricke C, Ulrich L, Kochmann J, Gergen J, Kovacikova K, Roth N, Beer J, Schnepf D, Mettenleiter TC, Rauch S, Petsch B, Hoffmann D, Beer M, Corleis B, Dorhoi A. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice Molecular therapy. Nucleic acids 35(4):102360 2024 [PMID: 39524696]
17. Klein EY, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel TP, Pecetta S, Bloom DE, Nandi A. Global trends in antibiotic consumption during 2016-2023 and future projections through 2030 Proceedings of the National Academy of Sciences of the United States of America 121(49):e2411919121 2024 [PMID: 39556760]
18. Shen XL, Jiang YH, Li SJ, Xie XY, Cheng Y, Wu L, Shen J, Chen W, Liu JR. Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China Brain, behavior, & immunity - health 42:100889 2024 [PMID: 39498382]
19. Wang H, Wei Y, Lin G, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study Emerging microbes & infections 13(1):2421397 2024 [PMID: 39497519]
20. Wang N, Fan H, Wang Y, Shu C, Lin Q, Hu P, Wang N, Zhang D. The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthrough infection Life sciences 358:123197 2024 [PMID: 39481835]
21. Isono T, Kojima A, Nishida T, Kobayashi Y, Ishiguro T, Takaku Y, Kagiyama N, Kurashima K. Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 During the Omicron Variant Period of the Pandemic Internal medicine (Tokyo, Japan) 2024 [PMID: 39566990]
22. Wiegand RE, Fireman B, Najdowski M, Tenforde MW, Link-Gelles R, Ferdinands JM. Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection Nature communications 15(1):10062 2024 [PMID: 39567531]
23. Gao P, Morita N, Shinkura R. Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers Seminars in immunopathology 47(1):1 2024 [PMID: 39567378]
24. Shuro L, Lawrence E, Knight L, Schneider H, Tabana H. Enhancing childhood immunization coverage in Mozambique and Malawi: Study protocol of a mixed methods evaluation of the 'Let's talk about vaccines' multisite community-based participatory project PloS one 19(11):e0311052 2024 [PMID: 39565783]
25. Markelz A, Zirnhelt Z, Morris K, Seys SA, Ruhland A, Fell A, Fess L, Como-Sabetti K, Meyer S. Association between age of paediatric index cases and household SARS-CoV-2 transmission Epidemiology and infection 152:e145 2024 [PMID: 39563607]
26. Lei H, Hong W, Yang J, He C, Zhou Y, Zhang Y, Alu A, Shi J, Liu J, Qin F, Ao D, Huang X, Chen Z, Yang H, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Li J, Yang L, Wang Z, Wang W, Shen G, Yang J, Zhao Z, Song X, Lu G, Sun Q, Wang Y, Lu S, Wei X. Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants Signal transduction and targeted therapy 9(1):311 2024 [PMID: 39562542]
27. Anders AG, Ruotolo BT. Ion Mobility-Mass Spectrometry Captures the Structural Consequences of Lipid Nanoparticle Encapsulation on Ribonucleic Acid Cargo Journal of the American Chemical Society 146(46):31885-31891 2024 [PMID: 39508132]
28. Herrera DJL, Herrera DJ, Anore KM, Herrera M, Masing ALA, Sanchez RE, Bas S, Amora D, Tabudlong RP, Berhe NM. Concordance, motivations and associated factors of COVID-19 vaccination among parent-child dyads: a cross-sectional study in Caraga Region, the Philippines BMJ open 14(11):e089178 2024 [PMID: 39566951]
29. Hohl CM, Yeom DS, Yan J, Archambault PM, Brooks SC, Morrison LJ, Perry J, Rosychuk R. Accuracy of the Canadian COVID-19 Mortality Score (CCMS) to predict in-hospital mortality among vaccinated and unvaccinated patients infected with Omicron: a cohort study BMJ open 14(11):e083280 2024 [PMID: 39566942]
30. Haaser T, Maternowski PJ, Marty S, Duc S, Mollier O, Poullenot F, Sureau P, Avérous V. Healthcare workers' opinions on non-medical criteria for prioritisation of access to care during the pandemic BMC medical ethics 25(1):133 2024 [PMID: 39563332]
31. Abbasi Kasbi N, Ghadiri F, Moghadasi AN, Khodaie F, Kohandel K, Rezaeimanesh N, Karaminia M, Sahraian MA. The impact of social and environmental factors on triggering multiple sclerosis onset, before and during the COVID-19 pandemic: a retrospective study from Iran BMC neurology 24(1):453 2024 [PMID: 39563293]
32. Sambo J, Sitoe N, Nguenha N, Chilaúle J, Guambe P, Langa D, Rafael J, Mudenyanga C, Mabunda N, Loquiha O, Jani I. Feasibility and Effectiveness of Using Community Testing Centers to Increase Access to COVID-19 Testing Services in Urban Mozambique The American journal of tropical medicine and hygiene 2024 [PMID: 39561400]
33. Etuk VP, Sanni C, Omonijo O, Atema SI, Lawal T, Yashim-Ankut AM, Ejinkeonye I, Onyegbutulem HC, Oyedele OK, Williams I, Andrew NP, Okpokoro E. Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria Transactions of the Royal Society of Tropical Medicine and Hygiene 2024 [PMID: 39558837]
34. Liu H, Liu T, Wang A, Liang C, Zhu X, Zhou J, Chen Y, Liu Y, Qi Y, Chen W, Zhang G. A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology Analytical chemistry 96(46):18437-18444 2024 [PMID: 39506608]
35. Somefun OD, Casale M, Ronnie GH, Sumankuuro J, Akintola O, Desmond C, Cluver L. Amplifying youth voices: young people's recommendations for policy and practice to enhance vaccine acceptability BMC health services research 24(1):1425 2024 [PMID: 39558407]
36. Gennaro FD, Veronese N, Segala FV, Frallonardo L, Guido G, Cormio M, Romita G, Parisi A, Marrone E, Ciuppa ME, Carrubba A, Carruba L, Licata A, Cavallaro G, Pagliuso V, Maino T, Lollo S, Latino L, Solimeo LT, Ianniello A, Montalbò D, Bavaro DF, Fiorella ML, Barbagallo M, Saracino A. Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study BMC infectious diseases 24(1):1313 2024 [PMID: 39558292]
37. Huang C, Smith RL. A modeling study on SARS-CoV-2 transmissions in primary and middle schools in Illinois BMC public health 24(1):3197 2024 [PMID: 39558201]
38. D'Souza M, Keeshan A, Gravel CA, Langlois MA, Cooper CL. Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity NPJ vaccines 9(1):226 2024 [PMID: 39557875]
39. Wang D, Mao Z, Yao X. Evaluating the World Health Organization's health promotion strategies: Sentiments, health beliefs, and the COVID-19 pandemic PloS one 19(11):e0311825 2024 [PMID: 39556583]
40. Ferroni E, Mateo-Urdiales A, Bietta C, Cesaroni G, Anticoli S, Di Maggio E, Ancona A, Petrone D, Cannone A, Sacco C, Fabiani M, Del Manso M, Riccardo F, Bella A, Ruggieri A, Pezzotti P. Sex differences in response to COVID-19 mRNA vaccines in Italian population Epidemiology and infection 152:e139 2024 [PMID: 39552125]
41. Abuyadek R, ElHafeez SA, Tahoun MM, Othman SS, Omran A, Fathy N, Ghazy RM. Development and validation of an Arabic tool for assessment of post-vaccination confidence in COVID-19 vaccines (ARAB-VAX-CONF) The Journal of the Egyptian Public Health Association 99(1):28 2024 [PMID: 39551890]
42. Ashley CL, Bloul M, Alca S, Smith L, Jin W, Khoury D, Counoupas C, Davenport M, Triccas JA, Steain M. Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants Journal of virological methods :115073 2024 [PMID: 39557342]
43. Wang L, Wan J, He W, Wang Z, Wu Q, Zhou M, Fu ZF, Zhao L. IL-7 promotes mRNA vaccine-induced long-term immunity Journal of nanobiotechnology 22(1):716 2024 [PMID: 39550592]
44. Kurokawa R, Ohde S, Kawaai S, Tamaki H. Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-center cross-sectional survey Modern rheumatology 2024 [PMID: 39548756]
45. Rahim FO, Fallah M, Jain U, Richardson ET, Ndembi N, Ngongo N, Kaseya J. Challenges and Ongoing Actions to Address the Mpox Emergency in Africa Annals of global health 90(1):68 2024 [PMID: 39554695]
46. Fisman D, Horton J, Oliver M, Ungrin M, Vipond J, Wright JM, Zoutman D. Canada needs a national COVID-19 inquiry now BMC medicine 22(1):537 2024 [PMID: 39548532]
47. Porras FM, Pineda G, Mangilog A, Hernandez K, Sikorski C, Lane M. A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection BMC infectious diseases 24(1):1308 2024 [PMID: 39548371]
48. Saif LJ. A Passion for Small Things and Staying Primed: My Career in Virology and Immunology Annual review of animal biosciences 2024 [PMID: 39546413]
49. Zhang WX, Zou L, Cui Y, Zhou Y, Zhang SS, Yang H, Ding S, Ma QY, Xi L, Zheng RR, Du J, Zhang J, Lu QB. Molecular epidemiology of herpangina in the subcenter of Beijing, China: a surveillance study during 2021-2022 Archives of virology 169(12):245 2024 [PMID: 39546035]
50. Chatterji S, Turuk A, Das P, Bhattacharya S, Mukherjee S, Ghosh PS, Chatterjee A, Mukerjee A, Kumar G, Satija A, Josten K, Bhalla A, Malhotra P, Bhuniya S, Talukdar A, Ghosh S, Misra S, Bhardwaj P, Chatterjee S, Menon GR, Deo V, Rao VV. Insights into cancer characteristics among SARS-CoV-2 infected hospitalized patients: a comprehensive analysis from the National Clinical Registry for COVID-19 Journal of cancer research and clinical oncology 150(11):500 2024 [PMID: 39546022]
51. . Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 [PMID: 39545819]
52. Brall C, Gille F, Schlaufer C, Porz R, Jox RJ. "I think all of us should have […] much better training in ethics." Ethical challenges in policy making during the COVID-19 pandemic: Results from an interview study with Swiss policy makers and scientists BMC medical ethics 25(1):129 2024 [PMID: 39543543]
53. Lehyen DB, Ako-Egbe L, Dwalu E, Vonhm BT, Thekkur P, Zachariah R, Bawo L. Health care workers hospitalized for COVID-19 in Liberia: who were they, and what were their outcomes? F1000Research 13:656 2024 [PMID: 39564431]
54. Chhor L, Saggese S, Hamilton GS, MacDonald MI. Clinical Characteristics and Outcomes of Hospitalized AECOPDs Secondary to SARS-CoV-2 versus Other Respiratory Viruses International journal of chronic obstructive pulmonary disease 19:2421-2430 2024 [PMID: 39559372]
55. Bernardes BG, Moura AD, Guarnieri JPO, Silva CFMD, Costa HHMD, Silva IGMD, Cordeiro KBB, Báo SN, Prudêncio CR, Lancellotti M. Vaccination with outer membrane vesicles from Neisseria Meningitidis and SBa15, SBa16 mesoporous silica associated with SARS-CoV-2 induces protective humoral and cellular response against COVID-19 in mice The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 28(6):104479 2024 [PMID: 39547005]
56. Floridia M, Giuliano M, Weimer LE, Ciardi MR, Agostoni P, Palange P, Rovere Querini P, Zucco S, Tosato M, Lo Forte A, Bonfanti P, Lacedonia D, Barisione E, Figliozzi S, Andreozzi P, Damiano C, Pricci F, Onder G. Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID BMC medicine 22(1):532 2024 [PMID: 39543596]
57. Pashaie F, Hoornweg TE, Bikker FJ, Veenendaal T, Broere F, Veldhuizen EJA. Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy Virus research 350:199496 2024 [PMID: 39528011]
58. van Elsland SL, O'Hare RM, McCabe R, Laydon DJ, Ferguson NM, Cori A, Christen P. Policy impact of the Imperial College COVID-19 Response Team: global perspective and United Kingdom case study Health research policy and systems 22(1):153 2024 [PMID: 39538321]
59. Velasco N, Herrera A, Trujillo-Diaz J, Amaya CA, González-Uribe C, Hernandez E. Design of logistics indicators for monitoring the COVID-19 vaccination process in Colombia : Logistic indicators for vaccination process BMC health services research 24(1):1397 2024 [PMID: 39538269]
60. Carnegie L, McCrone JT, du Plessis L, Hasan M, Ali MZ, Begum R, Hassan MZ, Islam S, Rahman MH, Uddin ASM, Sarker MS, Das T, Hossain M, Khan M, Razu MH, Akram A, Arina S, Hoque E, Molla MMA, Nafisaa T, Angra P, Rambaut A, Pullan ST, Osman KL, Hoque MA, Biswas P, Flora MS, Raghwani J, Fournié G, Samad MA, Hill SC. Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh Virology journal 21(1):291 2024 [PMID: 39538264]
61. Chen CC, Lin YA, Liu KT, Huang CY, Shih CM, Lee YT, Pan JL, Lee AW. Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges Virology journal 21(1):288 2024 [PMID: 39538233]
62. Franchi L, Atanasov V, Stake M, Bates G, Osinski K, Meurer JR, Black B. The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin Scientific reports 14(1):27850 2024 [PMID: 39537699]
63. Gijze S, Wasynczuk A, van Leeuwen L, Grobben M, van Gils MJ, Nouta J, Wang W, Dalm VA, Jolink H, Wuhrer M, Falck D. Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies Journal of proteome research 2024 [PMID: 39537390]
64. Schäfer A, Leist SR, Powers JM, Baric RS. Animal models of Long Covid: A hit-and-run disease Science translational medicine 16(773):eado2104 2024 [PMID: 39536118]
65. Hamlin RE, Pienkos SM, Chan L, Stabile MA, Pinedo K, Rao M, Grant P, Bonilla H, Holubar M, Singh U, Jacobson KB, Jagannathan P, Maldonado Y, Holmes SP, Subramanian A, Blish CA. Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution Science translational medicine 16(773):eadr1032 2024 [PMID: 39536117]
66. Zhang L, Cheng HH, Krüger N, Hörnich B, Graichen L, Hahn AS, Schulz SR, Jäck HM, Stankov MV, Behrens GMN, Müller MA, Drosten C, Mörer O, Winkler MS, Qian Z, Pöhlmann S, Hoffmann M. ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization PLoS pathogens 20(11):e1012653 2024 [PMID: 39536058]
67. Durán CE, Riefolo F, Gini R, Barbieri E, Messina D, Garcia P, Martin M, Villalobos F, Stona L, Carreras JJ, Urchueguía A, Correcher-Martínez E, Zhao J, Lupattelli A, Nordeng H, Sturkenboom M. Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway European journal of pediatrics 184(1):6 2024 [PMID: 39535547]
68. Chen Z, Xiao L, Zhou J, Wang W, Guo R, Li J, Li B. A new S1 subunit truncation vaccine induces effective protection against porcine deltacoronavirus in suckling piglets Veterinary microbiology 299:110303 2024 [PMID: 39536688]
69. Li Y, Qin S, Dong L, Xiao Y, Zhang Y, Hou Y, Qiao S, Zhang R, Li Y, Bao Y, Zhao X, Ma Y, Gao GF. Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineages EBioMedicine 110:105428 2024 [PMID: 39536392]
70. Faliti CE, Van TTP, Anam FA, Cheedarla N, Williams ME, Mishra AK, Usman SY, Woodruff MC, Kraker G, Runnstrom MC, Kyu S, Sanz D, Ahmed H, Ghimire M, Morrison-Porter A, Quehl H, Haddad NS, Chen W, Cheedarla S, Neish AS, Roback JD, Antia R, Hom J, Tipton CM, Lindner JM, Ghosn E, Khurana S, Scharer CD, Khosroshahi A, Lee FE, Sanz I. Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE Nature immunology 2024 [PMID: 39533072]
71. Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial Nature communications 15(1):9785 2024 [PMID: 39532861]
72. Khadka B, Napit R, Mihindukulasuriya KA, Shrestha S, Rauniyar R, Tuladhar ET, Droit L, Paredes AM, Jha R, Raut R, Jha BK, Handley SA, Elong-Ngono A, Shresta S, Wang D, Manandhar KD. Genomic surveillance of SARS-CoV-2 in Nepal Microbiology resource announcements :e0078924 2024 [PMID: 39530702]
73. Neilsen G, Mathew AM, Castro JM, McFadden WM, Wen X, Ong YT, Tedbury PR, Lan S, Sarafianos SG. Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles mBio :e0336823 2024 [PMID: 39530689]
74. Ohta M, Kawasaki K, Yamamoto R, Ishii K, Nakano K, Akada S, Doh K, Shimaoka M, Ota H, Moriuchi K, Shiro R, Yo Y, Yoshida K, Tohda Y, Matsumura N. Possible rapid reduction of anti-RBD antibody titre after SARS-CoV-2 mRNA vaccination in pregnant women: Multicentre prospective study The journal of obstetrics and gynaecology research 2024 [PMID: 39530282]
75. Gandini S, Conly J, Spencer EA, Evans D, Rosca EC, Brassey J, Maltoni S, Onakpoya I, Plüddemann A, Jefferson T, Heneghan C. Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential oro-faecal sources and evidence for transmission to humans Epidemiology and infection 152:e138 2024 [PMID: 39529596]
76. Vollmer M, Kuthning D, Gramenz J, Scholz A, Michael R, Wittmann N, Gesser U, Niesytto C, Vogler A, Tuxhorn V, Lenschow U, Lange A, Linnemann K, Lode H, Kaderali L, Meyer-Bahlburg A. Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study-the COVIDKID study PeerJ 12:e18384 2024 [PMID: 39544417]
77. Park B, Lee HA, Kim Y, Kim CH, Park H, Jun S, Lee H, Kwon SL, Heo Y, Lee H, Park H. Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea Journal of Korean medical science 39(43):e309 2024 [PMID: 39536790]
78. Li Y, Zhang X, Tai W, Zhuang X, Shi H, Liao S, Yu X, Mei R, Chen X, Huang Y, Liu Y, Liu J, Liu Y, Zhu Y, Wang P, Tian M, Yu G, Li L, Cheng G. A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity EBioMedicine 110:105437 2024 [PMID: 39531918]
79. Atashbahar O, Mohamadi E, Mostafavi H, Amiri MM, Takian A, Olyaeemanesh A. Exploring the factors influencing the adult population's reluctance to accept the COVID-19 vaccine in Tehran BMC health services research 24(1):1374 2024 [PMID: 39529041]
80. Beishuizen BHH, Stein ML, Buis JS, Tostmann A, Green C, Duggan J, Connolly MA, Rovers CP, Timen A. A systematic literature review on public health and healthcare resources for pandemic preparedness planning BMC public health 24(1):3114 2024 [PMID: 39529010]
81. Zhang X, Cheyne CP, Jones C, Humann M, Leeming G, Smith C, Hughes DM, Burnside G, Dodd S, Penrice-Randal R, Dong X, Semple MG, Neal T, Tunkel S, Fowler T, Turtle L, García-Fiñana M, Buchan IE. Can self-testing be enhanced to hasten safe return of healthcare workers in pandemics? Random order, open label trial using two manufacturers' SARS-CoV-2 lateral flow devices concurrently and nested viral culture study BMC infectious diseases 24(1):1276 2024 [PMID: 39528957]
82. Xu K, An Y, Liu X, Xie H, Li D, Yang T, Duan M, Wang Y, Zhao X, Dai L, Gao GF. Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera NPJ vaccines 9(1):215 2024 [PMID: 39528468]
83. Coughenour C, Chien LC, Labus B, Gakh M, Usufzy P. Shifting employment and perceptions of household responsibilities during early stages of the COVID-19 pandemic in Nevada, USA PloS one 19(11):e0309906 2024 [PMID: 39527611]
84. Li Y, Kong D, Ding Y, Wang J. The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis PloS one 19(11):e0308546 2024 [PMID: 39527538]
85. Ortiz N, Hoffman A, Schnall AH, Clara A, Lilo EA, Lofgren H, Guerrero L, Miller JS, Houck P, Weed N, Monterroso E. COVID-19 Prevention Practices and Vaccine Acceptability Among Hispanic and Non-Hispanic Households in an Agricultural Community-Washington, 2020 Disaster medicine and public health preparedness 18:e261 2024 [PMID: 39526416]
86. Case JB, Sanapala S, Dillen C, Rhodes V, Zmasek C, Chicz TM, Switzer CE, Scheaffer SM, Georgiev G, Jacob-Dolan C, Hauser BM, Dos Anjos DCC, Adams LJ, Soudani N, Liang CY, Ying B, McNamara RP, Scheuermann RH, Boon ACM, Fremont DH, Whelan SPJ, Schmidt AG, Sette A, Grifoni A, Frieman MB, Diamond MS. A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice Cell host & microbe 2024 [PMID: 39561781]
87. López-Macías C, Torres M, Armenta-Copca B, Wacher NH, Castro-Castrezana L, Colli-Domínguez AA, Rivera-Hernández T, Torres-Flores A, Damián-Hernández M, Ramírez-Martínez L, la Rosa GP, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Carranza C, Juárez E, Zamudio-Meza H, Carreto-Binaghi LE, Viettri M, Romero-Rodríguez D, Palencia A, Reyna-Rosas E, Márquez-García JE, Sarfati-Mizrahi D, Sun W, Chagoya-Cortés HE, Castro-Peralta F, Palese P, Krammer F, García-Sastre A, Lozano-Dubernard B. Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico Vaccine 43(Pt 2):126511 2024 [PMID: 39527880]
88. Zhapparova GA, Myrzakhmetova BS, Tlenchiyeva TM, Tussipova AA, Bissenbayeva KB, Toytanova AS, Kutumbetov LB. [Evaluation of the effectiveness of chemical inactivation and immunogenicity of the Omicron variant of the SARS-CoV-2 virus] Voprosy virusologii 69(5):459-469 2024 [PMID: 39527768]
89. Niemenoja O, Ämmälä AJ, Riihijärvi S, Lillrank P, Bono P, Taimela S. The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022 BMC public health 24(1):3100 2024 [PMID: 39522046]
90. Sardinha DM, Silva MJA, Lima KVB, Lima LNGC. Factors associated with outcome in a national cohort of rhinovirus hospitalized patients in Brazil in 2022 Scientific reports 14(1):27413 2024 [PMID: 39521845]
91. Chang F, Wu Q, Hu Y, Pan Z, Liu YC, Li YZ, Bostina M, Liu W, Zhao P, Qu X, Li YP. Engineered bispecific antibodies with enhanced breadth and potency against SARS-CoV-2 variants and SARS-related coronaviruses Medical microbiology and immunology 213(1):24 2024 [PMID: 39520579]
92. Chulanetra M, Punnakitikashem P, Mahasongkram K, Chaicumpa W, Glab-Ampai K. Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection Scientific reports 14(1):27311 2024 [PMID: 39516286]
93. Nakanishi A, Takahashi S, Inaba T, Yasutomi E, Colvin HS, Izumikawa K, Ishikawa S, Wato M, Ando M, Nakamura S. Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination: A Case Report Internal medicine (Tokyo, Japan) 2024 [PMID: 39523001]
94. Puri M, Veillard JH, Brown A, Klein D. A comparative analysis of supply chain factors impacting COVID-19 vaccine security in high-income countries (HICs) and low-income and middle-income countries (LMICs) BMJ global health 9(11) 2024 [PMID: 39521454]
95. Abuyadek R, Mousa M, AlAzazi J, Al Romaithi A, Selvaraj F, Alsafar H, Al Kaabi N, Al Hosani F. Genomic characteristics, disease outcome and heterologous vaccine effectiveness among cases with SARS CoV-2 infection BMC infectious diseases 24(1):1266 2024 [PMID: 39516737]
96. Phadnis R, Perera U, Lea V, Davlin S, Lee J, Siesel C, Abeygunathilaka D, Wickramasinghe SC. Designing and Validating a Survey for National-Level Data During the COVID-19 Pandemic in Sri Lanka: Cross-Sectional Mobile Phone Surveys JMIR formative research 8:e49708 2024 [PMID: 39514850]
97. Yang A, Edberg D. Interorganizational systems without hierarchy: immunization information systems Journal of health organization and management ahead-of-print(ahead-of-print) 2024 [PMID: 39514185]
98. Aneja S, Singh V, Narayan VV, Gohain M, Choudekar A, Gaur B, DeBord KR, Whitaker B, Krishnan A, Broor S, Saha S, Iuliano AD. Respiratory viruses associated with severe acute respiratory infection in children aged <5 years at a tertiary care hospital in Delhi, India during 2013-15 Journal of global health 14:04230 2024 [PMID: 39513276]
99. Kim DH, Ryu TH, Kim HY, Ahn JM, Oh JS, Kim JK. Enlarged lymph node occupying the retroperitoneal space and psoas muscle causes ureteric compression and graft kidney hydronephrosis after COVID-19 mRNA vaccine booster: a case report Clinical transplantation and research 2024 [PMID: 39510822]
100. Chen Z, Tsui JL, Gutierrez B, Busch Moreno S, du Plessis L, Deng X, Cai J, Bajaj S, Suchard MA, Pybus OG, Lemey P, Kraemer MUG, Yu H. COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses Science (New York, N.Y.) 386(6722):eadq3003 2024 [PMID: 39509510]
101. Peng X, Zhuo L, Ma Y, Liu Y, Wu Z. Causal association between COVID-19 vaccination and thrombosis-related biomarkers/thrombosis/ischemic stroke: Mendelian randomization study Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 34(1):108113 2024 [PMID: 39521256]
102. Portela MC, de Vasconcellos MTL, Lima SML, Caldas BDN, Martins M, de Andrade CLT, Amaral TLM, Amaral CA, Bernardino M, Soares L, Stelson E, Aveling EL, Rosenthal MB. Protocol for an ambidirectional cohort study on long COVID and the healthcare needs, use and barriers to access health services in a large city in Southeast Brazil BMJ open 14(11):e086656 2024 [PMID: 39515869]
103. Nugawela MD, Stephenson T, Shafran R, Chalder T, Dalrymple E, Ford T, Fox-Smith L, Harnden A, Heyman I, Ladhani SN, McOwat K, Simmons R, Swann O, Whittaker E, Pinto Pereira SM. Predicting post-COVID-19 condition in children and young people up to 24 months after a positive SARS-CoV-2 PCR-test: the CLoCk study BMC medicine 22(1):520 2024 [PMID: 39511637]
104. Flores W, Sullivan A, Jerez F, Rodríguez DC. The politics of health systems policies during COVID-19: reflections on experiences from Latin America and the Caribbean International journal for equity in health 23(1):228 2024 [PMID: 39511604]
105. Kimmig C, Langer T, Loy JK, Bender S, Haddad A. Children and adolescents' experiences of mandatory SARS-CoV-2 testing in schools: a cross-sectional survey BMJ paediatrics open 8(1) 2024 [PMID: 39510767]
106. Ezezika O, Kotsaftis TS, Amponsah-Dacosta E, Demi S, Omwenga EO, Mong'are S, Zaranyika T, Ariyo O, Ngianga-Bakwin K, Ameyaw EK. A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries PloS one 19(11):e0311800 2024 [PMID: 39509409]
107. Chewaskulyong B, Satjaritanun P, Ketpueak T, Suksombooncharoen T, Charoentum C, Nuchpong N, Tantraworasin A. Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients PloS one 19(11):e0310781 2024 [PMID: 39509358]
108. de Cos V, Naugle K, Baker O, Kocharian E, Moshtaghi O, Dixon PR, Matsuoka A, Harris JP. Neighborhood Socioeconomic Disadvantage Increases Risk of Severe Acute Respiratory Syndrome Coronavirus 2-Mediated Otologic Dysfunction The Laryngoscope 2024 [PMID: 39508181]
109. Lamers OAC, Roestenberg M, de Vries MC, Hoogerwerf MA. What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study Trials 25(1):740 2024 [PMID: 39506878]
110. Miao M, Ma Y, Tan J, Chen R, Men K. Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data Scientific reports 14(1):26992 2024 [PMID: 39506014]
111. Feng Q, Cheng K, Zhang L, Wang D, Gao X, Liang J, Liu G, Ma N, Xu C, Tang M, Chen L, Wang X, Ma X, Zou J, Shi Q, Du P, Wang Q, Wang H, Nie G, Zhao X. Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain Nature communications 15(1):9581 2024 [PMID: 39505890]
112. Babcock BR, Kosters A, Eddins DJ, Donaire MSB, Sarvadhavabhatla S, Pae V, Beltran F, Murray VW, Gill G, Xie G, Dobosh BS, Giacalone VD, Tirouvanziam RM, Ramonell RP, Jenks SA, Sanz I, Lee FE, Roan NR, Lee SA, Ghosn EEB. Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19 Science translational medicine 16(772):eadq1789 2024 [PMID: 39504354]
113. Petro CD, Hooper AT, Peace A, Mohammadi K, Eagan W, Elbashir SM, DiPiazza A, Makrinos D, Pascal K, Bandawane P, Durand M, Basu R, Coppi A, Wang B, Golubov J, Asrat S, Ganguly S, Koehler-Stec EM, Wipperman MF, Ehrlich G, Gonzalez Ortiz AM, Isa F, Lewis MG, Andersen H, Musser BJ, Torres M, Lee WY, Edwards D, Skokos D, Orengo J, Sleeman M, Norton T, O'Brien M, Forleo-Neto E, Herman GA, Hamilton JD, Murphy AJ, Kyratsous CA, Baum A. Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection Science translational medicine 16(772):eadn0396 2024 [PMID: 39504352]
114. Dey M, Doskaliuk B, Parodis I, Lindblom J, Wincup C, Joshi M, Dey D, Katchamart W, Kadam E, Sen P, Shinjo SK, Nune A, Goo PA, Ziade N, Chen YM, Traboco LS, Gutiérrez CET, Vaidya B, Agarwal V, Gupta L, Nikiphorou E. COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey Rheumatology international 2024 [PMID: 39503760]
115. Greninger AL, Larcena A, Patel A, Webster B, Ulen C, Green DF, King D, Patel DR, McElvania E, Harnett G, Jandali I, Gibson J, Killion J, Atwi J, Bergmann K, Slade L, Allen Staat M, Faron M, Washington M, Patel R, Annamalai R, Ackerman R, Stewart WP 3rd, Amador YM, Rao D, Liu X, Raman A. Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Journal of clinical microbiology :e0121924 2024 [PMID: 39503494]
116. An R, Yang H, Tang C, Li Q, Huang Q, Wang H, Wang J, Zhou Y, Yang Y, Chen H, Yu W, Li B, Wu D, Zhang Y, Luo F, Quan W, Xu J, Lin D, Liang X, Yan Y, Yuan L, Du X, Yuan Y, Li Y, Sun Q, Wang Y, Lu S. A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2 Signal transduction and targeted therapy 9(1):301 2024 [PMID: 39500906]
117. Sultana R, Stahelin RV. Strengths and limitations of SARS-CoV-2 virus-like particle systems Virology 601:110285 2024 [PMID: 39536645]
118. Yuxi-Shen, Shunyi-Fan, Shuyun-Li, Andong-Wang, Xuelian-Xiang, Yamei-Huang, Haili-Zhang, Min-Cui, Jing-Xia, Yong-Huang. Mapping and functional analysis of S1 subunit glycosylation of avian infectious bronchitis virus International journal of biological macromolecules :137050 2024 [PMID: 39510483]
119. Tyagi S, Tyagi N, Singh A, Gautam A, Singh A, Jindal S, Singh RP, Chaturvedi R, Kushwaha HR. Linking COVID-19 and cancer: Underlying mechanism Biochimica et biophysica acta. Molecular basis of disease 1871(1):167563 2024 [PMID: 39510388]
120. Clark JJ, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F. Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination Cell reports 43(11):114922 2024 [PMID: 39504245]
121. Pignolo RJ, King KS, Wi CI, Ryu E, Takahashi PY, Yao JD, Binnicker MJ, Dixon RE, Natoli TL, Juhn YJ. Characteristics of an Older Adult Population Without COVID-19 Infection in a Southeast Minnesota Community Mayo Clinic proceedings 2024 [PMID: 39503643]
122. Maher S, Assaly NME, Aly DM, Atta S, Fteah AM, Badawi H, Zahran MY, Kamel M. Comparative study of neutralizing antibodies titers in response to different types of COVID-19 vaccines among a group of egyptian healthcare workers Virology journal 21(1):277 2024 [PMID: 39501293]
123. Lucinde RK, Gathuri H, Isaaka L, Ogero M, Mumelo L, Kimego D, Mbevi G, Wanyama C, Otieno EO, Mwakio S, Saisi M, Isinde E, Oginga IN, Wachira A, Manuthu E, Kariuki H, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi D, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Ahmed N, Gituma B, Giabe M, Omondi C, Aman R, Amoth P, Kasera K, Were F, Nganga W, Berkley JA, Tsofa B, Mwangangi J, Bejon P, Barasa E, English M, Scott JAG, Akech S, Kagucia EW, Agweyu A, Etyang AO. Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic BMC infectious diseases 24(1):1246 2024 [PMID: 39501217]
124. Zhao J, Wu S, Rafal RA, Manguerra H, Dong Q, Huang H, Lau L, Wei X. Vaccine equity implementation: exploring factors influencing COVID-19 vaccine delivery in the Philippines from an equity lens BMC public health 24(1):3058 2024 [PMID: 39501210]
125. Brisson J, Balasa R, Bowra A, Hill DC, Doshi AS, Tan DHS, Perez-Brumer A. Motivations for enrollment in a COVID-19 ring-based post-exposure prophylaxis trial: qualitative examination of participant experiences BMC medical research methodology 24(1):267 2024 [PMID: 39501157]
126. Doroud D, Sadat Larijani M, Biglari A, Ashrafian F, Sabouni T, Eybpoosh S, Verez-Bencomo V, Valdés-Balbín Y, García-Rivera D, Herrera-Rojas Y, Climent-Ruiz Y, Santana-Mederos D, Ramezani A. Comparative assessment of a COVID-19 vaccine after technology transfer to Iran from critical quality attributes to clinical and immunogenicity aspects Scientific reports 14(1):26793 2024 [PMID: 39501012]
127. Ayaz H, Celik MH, Koytak HZ, Yanik IE. Exploring vaccine hesitancy in digital public discourse: From tribal polarization to socio-economic disparities PloS one 19(11):e0308122 2024 [PMID: 39499705]
128. Chen D, Zhang W, Xiao B, Xu B, Yang X, Deng S, Li G, Yang G, Cao J, Mei X, Luo Q, Huang P, Sun X, Su J, Zhong N, Zhao Z, Wang Z. Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk Journal of virology :e0128524 2024 [PMID: 39499071]
129. Sussman F, Villaverde DS. On the Nature of the Interactions That Govern COV-2 Mutants Escape from Neutralizing Antibodies Molecules (Basel, Switzerland) 29(21) 2024 [PMID: 39519847]
130. Jorda A, Ensle D, Eser H, Glötzl F, Riedl B, Szell M, Valipour A, Zoufaly A, Wenisch C, Haider D, Burgmann H, Thalhammer F, Götzinger F, Jilma B, Ristl R, Karnthaler U, Zeitlinger M. Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalised adults with Covid-19: a population-based, retrospective cohort study cohort study Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2024 [PMID: 39505067]
131. Walter EB, Schlaudecker EP, Talaat KR, Rountree W, Broder KR, Duffy J, Grohskopf LA, Poniewierski MS, Spreng RL, Staat MA, Tekalign R, Museru O, Goel A, Davis GN, Schmader KE. Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial JAMA network open 7(11):e2443166 2024 [PMID: 39504023]
132. Erkihun M, Ayele B, Asmare Z, Endalamaw K. Current Updates on Variants of SARS-CoV- 2: Systematic Review Health science reports 7(11):e70166 2024 [PMID: 39502131]
133. Park H, Lim E, Jun S, Lee H, Lee HA, Park H, Choi NK, Park B. Reported Adverse Events and Associated Factors in Korean Coronavirus Disease 2019 Vaccinations Journal of Korean medical science 39(42):e274 2024 [PMID: 39497564]
134. Shimizu J, Sasaki T, Ong GH, Koketsu R, Samune Y, Nakayama EE, Nagamoto T, Yamamoto Y, Miyazaki K, Shioda T. IFN-γ derived from activated human CD4(+) T cells inhibits the replication of SARS-CoV-2 depending on cell-type and viral strain Scientific reports 14(1):26660 2024 [PMID: 39496837]
135. Al Baseer NAM, Shaheen HS. A study of some psychological variables as predictors of COVID-19 vaccination anxiety among Faculty Members of Ain Shams University Scientific reports 14(1):26615 2024 [PMID: 39496619]
136. Nanteza MB, Nanyonjo G, Kyakuwa N, Nakanjako F, Kalute H, Atuhairwe C, Watera C, Ssemwanga D. COVID-19 vaccine uptake and associated factors among individuals living in a peri-urban area in Uganda: A cross-sectional study PloS one 19(11):e0312377 2024 [PMID: 39495801]
137. Hoang TNA, Byrne A, Quach HL, Bannister-Tyrrell M, Vogt F. How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Transactions of the Royal Society of Tropical Medicine and Hygiene 2024 [PMID: 39495246]
138. Prado ADS, Baldofski S, Kohls E, Bianchi AS, Oda FS, Freitas JL, Rummel-Kluge C. Cross-country comparison of depressive symptoms and social-emotional aspects in university students from Brazil and Germany during the COVID-19 pandemic: results from two cross-sectional surveys BJPsych open 10(6):e193 2024 [PMID: 39494847]
139. Green B. Public perceptions of the Hippocratic Oath in the U.K. 2023 BMC medical ethics 25(1):125 2024 [PMID: 39491011]
140. Hitch D, Angeles MR, Lau E, Nicola-Richmond K, Bennett C, Said CM, Holton S, Haines K, Rasmussen B, Pepin G, Richards K, Hensher M. Hospital costs of COVID-19, post-COVID-19 condition and other viral pneumonias: a cost comparison analysis The Medical journal of Australia 221 Suppl 9:S23-S30 2024 [PMID: 39489521]
141. Liu S, Wen Y, Shan X, Ma X, Yang C, Cheng X, Zhao Y, Li J, Mi S, Huo H, Li W, Jiang Z, Li Y, Lin J, Miao L, Lu X. Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination Nature communications 15(1):9471 2024 [PMID: 39488531]
142. Caffrey AR, Appaneal HJ, Lopes VV, Puzniak L, Zasowski EJ, Jodar L, LaPlante KL, McLaughlin JM. Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System Nature communications 15(1):9490 2024 [PMID: 39488521]
143. Baek K, Kim D, Kang BM, Kim J, Demirev AV, Lee S, Kim M, Kim S, Park S, Kim JI, Park MS, Lee Y, Kwon HJ. Parental Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Predominates Over Coinfected SARS-CoV-2 Delta, Producing Less Lethal Variants in a Long-Term Replication Mouse Model Journal of medical virology 96(11):e70072 2024 [PMID: 39564900]
144. Milind, Tak S, Nayak S, Prajapati GR, Vyas A, Potaliya U. A Retrospective Observational Study to Compare the Clinical and Laboratory Parameters of Patients Requiring Hospitalization during 3rd Wave vs 2nd Wave of Coronavirus Disease 2019 The Journal of the Association of Physicians of India 72(11):49-52 2024 [PMID: 39563117]
145. de Miguel-Perez D, Arroyo-Hernandez M, La Salvia S, Gunasekaran M, Pickering EM, Avila S, Gebru E, Becerril-Vargas E, Monraz-Perez S, Saharia K, Grazioli A, McCurdy MT, Frieman M, Miorin L, Russo A, Cardona AF, García-Sastre A, Kaushal S, Hirsch FR, Atanackovic D, Sahoo S, Arrieta O, Rolfo C. Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19 Journal of extracellular vesicles 13(11):e70001 2024 [PMID: 39558820]
146. Sun H, Liu K, Yu B, Zhu M, Jia L, Yao W, Chen Z, Hao H, Zhang X, Liu Y, Liu H, Shan C, Huang F, Guan W. Characterization of the Pathogenic Features of Multiple SARS-CoV-2 Pandemic Strains in Different Mouse Models Journal of medical virology 96(11):e70049 2024 [PMID: 39558699]
147. Konono KCC, Msusa K, Mpinganjira S, Amani A, Nyagupe C, Ngigi M. Technological Barriers to Routine Genomic Surveillance for Vaccine Development Against SARS-CoV-2 in Africa: A Systematic Review Influenza and other respiratory viruses 18(11):e70047 2024 [PMID: 39557412]
148. Hassan MM, Sikandar SM, Jamal F, Ameeq M, Kargbo A. The Complex Relationship Between Chronic Obstructive Pulmonary Disease With Cardiovascular Disease and Their Interactions With COVID-19 Vaccination: A Retrospective Study Immunity, inflammation and disease 12(11):e70068 2024 [PMID: 39555721]
149. Hoxha A, Striani G, Lovisotto M, Simioni P, Doria A, Ramonda R. COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis Frontiers in immunology 15:1503895 2024 [PMID: 39555064]
150. Salum GM, Abd El Meguid M, Fotouh BE, Dawood RM. Impacts of host factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression Journal of immunoassay & immunochemistry 45(6):493-517 2024 [PMID: 39552098]
151. Saiman L, Walsh EE, Branche AR, Barrett A, Alba L, Gollerkeri S, Schillinger JA, Phillips M, Finelli L. Impact of Age and Comorbid Conditions on Incidence Rates of COVID-19-Associated Hospitalizations, 2020-2021 Influenza and other respiratory viruses 18(11):e70016 2024 [PMID: 39551610]
152. Boongird S, Srithongkul T, Sethakarun S, Bruminhent J, Kiertiburanakul S, Nongnuch A, Kitiyakara C, Sritippayawan S. Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study Clinical kidney journal 17(11):sfae309 2024 [PMID: 39539359]
153. Carvalho HMB, Fidalgo TAS, Acúrcio RC, Matos AI, Satchi-Fainaro R, Florindo HF. Better, Faster, Stronger: Accelerating mRNA-Based Immunotherapies With Nanocarriers Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 16(6):e2017 2024 [PMID: 39537215]
154. Espi M, Charmetant X, Benotmane I, Lefsihane K, Barateau V, Gallais F, Boulenouar H, Ovize A, Barbry A, Bouz C, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Memory B Cells Provide Long-Term Protection to Vaccinated Kidney Transplant Recipients Against SARS-CoV-2 Variants Journal of medical virology 96(11):e70037 2024 [PMID: 39530340]
155. Ouarab M, Bouaiti E, Rhazzar Z, El Annaz H, Kochri SE, Hemlali M, Ghammaz H, Nyabi O, Bakkouri KE, Touil N, Elouennass M, Belayachi L, Gala JL, Ennibi K, El Fahime E. Immunogenicity of two-dose sinopharm BBIB-CorV vaccine in Morocco: One-year follow-up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern Immunity, inflammation and disease 12(11):e1359 2024 [PMID: 39530285]
156. Facco JV, Addas-Carvalho M, Duarte ADSS, Zangirolami AB, Benites BD, Saad STO. HLA-B*15 Is Associated With SARS-CoV-2 Infection in a Brazilian Population Journal of medical virology 96(11):e70028 2024 [PMID: 39530176]
157. Banga J, Brock-Fisher T, Petros BA, Dai EY, Leonelli AT, Dobbins ST, Messer KS, Nathanson AB, Capone A, Littlehale N, Appiah-Danquah V, Dim S, Moreno GK, Crowther M, DeRuff KC, MacInnis BL, Springer M, Sabeti PC, Stephenson KE. Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology Open forum infectious diseases 11(11):ofae591 2024 [PMID: 39529936]
158. Merdrignac L, Laniece Delaunay C, Verdasca N, Vega-Piris L, O'Donnell J, Sève N, Trobajo-Sanmartín C, Buda S, Hooiveld M, Rodrigues AP, Túri G, Latorre-Margalef N, Mlinarić I, Lazar M, Maurel M, Castrillejo D, Bennett C, Rameix-Welti MA, Martínez-Baz I, Dürrwald R, Meijer A, Melo A, Oroszi B, Hagey TS, Kurečić Filipović S, Dijkstra F, Gomez V, Bacci S, Kaczmarek M, Kissling E. Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024 Influenza and other respiratory viruses 18(11):e70009 2024 [PMID: 39523781]
159. Ciesla AA, Mak J, Roper LE, Fleming-Dutra KE, Smith ZR, Wiegand RE, Britton A, Miller J, Link-Gelles R. Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023 Influenza and other respiratory viruses 18(11):e70038 2024 [PMID: 39522959]
160. Wu H, Fujioka Y, Sakaguchi S, Suzuki Y, Nakano T. Electron Tomography as a Tool to Study SARS-CoV-2 Morphology International journal of molecular sciences 25(21) 2024 [PMID: 39519314]
161. Deng E, Craig TJ, Nguyen DV, Al-Shaikhly T. COVID-19 and severe cutaneous allergic reactions to sulfonamides Allergy and asthma proceedings 45(6):e93-e100 2024 [PMID: 39517080]
162. Huang YC, Caldarone L, Sherman C, Deutsch R, Ahn J, Bellanti JA. The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis Allergy and asthma proceedings 45(6):438-446 2024 [PMID: 39517070]
163. Nourafkan E, Kenyon C, Nair A, Loveday KA, Welbourne EN, Tao M, Ahmed M, Middleton J, Dickman MJ, Brown SF, Maamra M, Cordiner J, Kis Z. An Experimental and Modeling Approach to Study Tangential Flow Filtration Performance for mRNA Drug Substance Purification Biotechnology journal 19(11):e202400473 2024 [PMID: 39513347]
164. Sinnathamby MA, Bourouphael T, Boateng J, Collonnaz M, Quinot C, Aziz NA, Elgohari S, Green RE, Dabrera G, Lopez-Bernal J, Allen A. Setting thresholds to determine COVID-19 activity levels using the mean standard deviation (MSD) method, England, 2022-2024 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(45) 2024 [PMID: 39512168]
165. Del Riccio M, Nunes MC, Cowling BJ, Lina B, McCauley JW, Meijer A, Nohynek H, Boudewijns B, Caini S. Post-disappearance scenarios: policy implications following the potential disappearance of B/Yamagata lineage influenza viruses Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(45) 2024 [PMID: 39512167]
166. Roshanzamir Z, Mohammadi F, Yadegar A, Naeini AM, Hojabri K, Shirzadi R. An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future Immunity, inflammation and disease 12(11):e70049 2024 [PMID: 39508631]
167. Natarajan N, Al-Mohammad A, Ngan T, Dutta Roy S. Is it just another case of vaccine-induced myocarditis? A case report and key insights European heart journal. Case reports 8(11):ytae531 2024 [PMID: 39502259]
168. Fukae S, Yamanaka K, Matsumura S, Tanaka R, Nakazawa S, Kakuta Y, Nonomura N. Cranial neuropathy following coronavirus disease 2019 vaccination in kidney transplant recipients IJU case reports 7(6):423-426 2024 [PMID: 39498178]
169. DeCuir J, Surie D, Zhu Y, Lauring AS, Gaglani M, McNeal T, Ghamande S, Peltan ID, Brown SM, Ginde AA, Steinwand A, Mohr NM, Gibbs KW, Hager DN, Ali H, Frosch A, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Busse LW, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Exline MC, Shapiro NI, Columbus C, Vaughn IA, Ramesh M, Safdar B, Mosier JM, Casey JD, Talbot HK, Rice TW, Halasa N, Chappell JD, Grijalva CG, Baughman A, Womack KN, Rhoads JP, Swan SA, Johnson C, Lewis N, Ellington S, Dawood FS, McMorrow M, Self WH. Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023 Influenza and other respiratory viruses 18(11):e70027 2024 [PMID: 39496339]
170. Sherman JD, Karmali V, Kumar B, Simon TW, Bechnak S, Panjwani A, Ciric CR, Wang D, Huerta C, Johnson B, Anderson EJ, Rouphael N, Collins MH, Rostad CA, Azadi P, Scherer EM. Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children Open forum infectious diseases 11(11):ofae626 2024 [PMID: 39494457]
171. O'Carroll A, Richard SA, Byrne C, Rusiecki J, Wier B, Berjohn CM, Fries AC, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Schofield C, Lindholm DA, Mende K, Jones MU, Flanagan R, Larson DT, Ewers EC, Saunders D, Maves RC, Maldonado CJ, Sanchez Edwards M, O'Connell RJ, Simons MP, Tribble DR, Agan BK, Burgess TH, Pollett SD. Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk Open forum infectious diseases 11(11):ofae557 2024 [PMID: 39494453]
172. Sinha DD, Foeller M, Bell AS, Nixon AJ Jr, Hudson D, James AS, Scheffer AR, Baumann AA, Diveley E, Carter EB, Raghuraman N, Mysorekar IU, Kelly JC. Experiences of Midwestern obstetric clinicians during the Coronavirus disease 2019 pandemic AJOG global reports 4(4):100392 2024 [PMID: 39493438]
173. Nosaka T, Ohtsuka J, Ohtsuka T, Fukumura M. Next Generation RNA/Protein-Carrying Vector With Pleiotropic Activity Reviews in medical virology 34(6):e70008 2024 [PMID: 39488720]
174. Hohn O, Meixenberger K, Volkwein A, Körner K, Icli S, Koppe U, Hower M, Bremer V, Gunsenheimer-Bartmeyer B, Bannert N. SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020-2022 BMC infectious diseases 24(1):1228 2024 [PMID: 39487409]
175. Lei Z, Liu D, Chen L, Chang Y, Wang X, Fan S, Ding Z, Chen H. Factors influencing COVID-19 vaccination intentions and mediating effects among older adults in Southwest China Scientific reports 14(1):26357 2024 [PMID: 39487214]
176. Ellermann C, Savaskan N, Rebitschek FG. Do summaries of evidence enable informed decision-making about COVID-19 and influenza vaccination equitably across more and less disadvantaged groups? Study protocol for a multi-centre cluster randomised controlled trial of 'fact boxes' in health and social care in Germany BMJ open 14(10):e083515 2024 [PMID: 39486820]
177. Kuddus MA, Mohiuddin M, Paul AK, Rahman A. Insights from qualitative and bifurcation analysis of COVID-19 vaccination model in Bangladesh PloS one 19(11):e0312780 2024 [PMID: 39485754]
178. Klegerman ME, Peng T, Seferovich I, Rahbar MH, Hessabi M, Tahanan A, Wanger A, Grimes CZ, Ostrosky-Zeichner LZ, Koster K, Cirillo JD, Abeydeera D, De Lira S, McPherson DD. Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies PloS one 19(11):e0311777 2024 [PMID: 39485748]
179. C M, M D, Kl F, M P, H M, J M, Mj E, J R, U W, Pcm W, Mc T, C B, K S, S N, S N F, Rb T, A M, T S, P R. The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol Trials 25(1):735 2024 [PMID: 39482706]
180. Lv X, Zhao H, Niu X, Wu Y, Wang M, Chen J, Song L. Effect of COVID-19 vaccine in adults infected with the Delta variant of SARS-CoV-2: a retrospective cohort study Journal of thoracic disease 16(10):6983-6998 2024 [PMID: 39552877]
181. Imazio M, Sukmarova ZN, Nasonov EL. [Complex Issues in the Management of Pericarditis. In Anticipation of the Release of Updated Recommendations of the European Society of Cardiology] Kardiologiia 64(10):57-61 2024 [PMID: 39526519]
182. Chang LY, Chao CY, Huang JL, Chen YY, Wang CY, Lee WL, Lin WW. Impact of the Coronavirus Disease 2019 [COVID-19] Pandemic on Post-Acute Care of Patients with Heart Failure and the Effectiveness of Vaccine Prevention Healthcare (Basel, Switzerland) 12(21) 2024 [PMID: 39517383]
183. Doyle D, Dalton B, Zhang Z, Sabuda D, Rajakumar I, Rennert-May E, Leal J, Conly JM. A quasi-experimental analysis comparing antimicrobial usage on COVID-19 and non-COVID-19 wards Antimicrobial stewardship & healthcare epidemiology : ASHE 4(1):e192 2024 [PMID: 39483329]
184. Dimitrov Y, Krummel T, Chantrel F, Heibel F, Kribs M, Hannedouche T. Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study BMC nephrology 25(1):391 2024 [PMID: 39482652]
185. Ideguchi S, Miyagi K, Kami W, Tasato D, Higa F, Maeshiro N, Nagamine S, Nakamura H, Kinjo T, Nakamatsu M, Haranaga S, Tokushige A, Ueda S, Fujita J, Yamamoto K. Clinical features of and severity risk factors for COVID-19 in adults during the predominance of SARS-CoV-2 XBB variants in Okinawa, Japan PloS one 19(10):e0309808 2024 [PMID: 39480756]
186. Eguchi G, Murakoshi M, Miyaoka F, Shimbo A, Irabu H, Kanamori T, Udagawa T, Morio T, Shimizu M. Acute tubulointerstitial nephritis following coronavirus disease 2019 mRNA vaccination: a pediatric case report CEN case reports 2024 [PMID: 39480621]
187. Song YY, Xu L, Liu D, Feng M, Yang C, Jiang Y, Wu Y. Perceived protective behavioral changes in Chinese residents post-dynamic zero-COVID policy lifting: a cross-sectional study Frontiers in public health 12:1439749 2024 [PMID: 39540099]
188. Rexhepaj M, Asarnow D, Perruzza L, Park YJ, Guarino B, Mccallum M, Culap K, Saliba C, Leoni G, Balmelli A, Yoshiyama CN, Dickinson MS, Quispe J, Brown JT, Tortorici MA, Sprouse KR, Taylor AL, Corti D, Starr TN, Benigni F, Veesler D. Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses Immunity 2024 [PMID: 39488210]
189. Xu X, Sun J, Zheng H, Du X, Wang Y, Cheng J, Liu Y, Ying J, Zhao Y, Wang Z, Yan J, Duan X, Yang Y, Ye Z, Sun D, Song H, Su M. Isolation and characterization of a novel S-gene mutation porcine deltacoronavirus with high pathogenicity from diarrhea piglet in Zhejiang Province, China, 2022 Microbial pathogenesis 197:107095 2024 [PMID: 39486553]
190. Choi SK, Kim S, Ko M, Heo Y, Kim TE, Lee Y, Jang J, Bahng E. Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea Osong public health and research perspectives 2024 [PMID: 39557576]
191. García AH, De Sanctis JB. Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era International journal of molecular sciences 25(21) 2024 [PMID: 39519178]
192. Laghlali G, Wiest MJ, Karadag D, Warang P, O'Konek JJ, Chang LA, Park SC, Yan V, Farazuddin M, Janczak KW, García-Sastre A, Baker JR Jr, Wong PT, Schotsaert M. Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant Molecular therapy : the journal of the American Society of Gene Therapy 2024 [PMID: 39489918]
193. Mori T, Kitano T, Kitagawa D, Murata M, Onishi M, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Onaka M, Suzuki R, Sekine M, Suzuki S, Nakamura F, Yoshida S. Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era Journal of infection and public health 17(12):102570 2024 [PMID: 39481292]
194. Cobre AF, Fachi MM, Domingues KZA, Lazo REL, Ferreira LM, Tonin FS, Pontarolo R. Accuracy of COVID-19 diagnostic tests via infrared spectroscopy: A systematic review and meta-analysis Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 327:125337 2024 [PMID: 39481165]
195. Cui J, Hu A, Xiong X, Wang Q, Zhu C, Chen Z, Lu Y, Xia X, Chen H, Liu G. Optimization of PCA Error Correction Conditions to Improve Efficiency of Virus Genome De Novo Synthesis International journal of molecular sciences 25(21) 2024 [PMID: 39519066]
196. Cossu C, Franceschi V, Di Lorenzo A, Bolli E, Minesso S, Cotti C, Conti L, Donofrio G. Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern International journal of molecular sciences 25(21) 2024 [PMID: 39519062]
197. Nowak KD, Lane MA, Mbanya A, Carter JR, Binion BA, Espinoza DO, Collins MH, Heaney CD, Pisanic N, Kruczynski K, Spicer K, Rivera MG, Glover F, Ojo-Akosile T, Breiman RF, Anderson EJ, Lobelo F, Fairley JK. High SARS-CoV-2 secondary infection rates in households with children in Georgia, United States, Fall 2020-Winter 2021 Frontiers in public health 12:1378701 2024 [PMID: 39525464]
198. Bozkus CC, Brown M, Velazquez L, Thomas M, Wilson EA, O'Donnell T, Ruchnewitz D, Geertz D, Bykov Y, Kodysh J, Oguntuyo KY, Roudko V, Hoyos D, Srivastava KD, Kleiner G, Alshammary H, Karekar N, McClain C, Gopal R, Nie K, Del Valle D, Delbeau-Zagelbaum D, Rodriguez D, Setal J, Carroll E, Wiesendanger M, Gulko PS, Charney A, Merad M, Kim-Schulze S, Lee B, Wajnberg A, Simon V, Greenbaum BD, Chowell D, Vabret N, Luksza M, Bhardwaj N. T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome bioRxiv : the preprint server for biology 2024 [PMID: 39484455]
199. Beatrici NZ, Knobel R, Vieira MS, Alexandrini IF, Trapani A, Andreucci CB. Access and adequacy of antenatal care in a city in Brazil during two phases of the COVID-19 pandemic Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 46 2024 [PMID: 39530072]
200. Wan L, Xie B, Shuda M, Delgoffe G, Chang Y, Moore PS. Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens bioRxiv : the preprint server for biology 2024 [PMID: 39484438]
201. Lionaki S, Dounousi E, Marinaki S, Kantartzi K, Papasotiriou M, Galitsiou D, Bellos I, Sardeli A, Kalogeropoulos P, Liakopoulos V, Mpintas C, Goumenos D, Flouda S, Venetsanopoulou A, Voulgari P, Andronikidi E, Moustakas G, Panagoutsos S, Boletis I. The clinical course of SARS-CoV-2 infection in patients with glomerular diseases and evaluation of the subsequent risk of relapse Frontiers in nephrology 4:1472294 2024 [PMID: 39497750]
202. Staccioli S, Mariani R, Bompard S, Olivini N, Fanfoni C, Mirra G, Bisozzi E, Campana A, Lettori D. Alice in Wonderland Syndrome in Children With Severe Acute Respiratory Syndrome SARS-CoV-2 Infection: A Case Series of Two Patients in an Italian Hospital Pediatric neurology 162:28-31 2024 [PMID: 39531962]
203. Kyriakopoulos AM, Nigh G, McCullough PA, Seneff S. Clinical rationale for dietary lutein supplementation in long COVID and mRNA vaccine injury syndromes F1000Research 13:191 2024 [PMID: 39526116]
204. Catalano HP, Christofora J, Richards K, Hyatt Hawkins Shaw K, Kiser K. Predicting COVID-19 booster intentions among college students using the health belief model: advancing health promotion strategies for uptake Frontiers in public health 12:1395941 2024 [PMID: 39484358]
205. Shahrbaf M, Alimohamadi Y, Yousefi Arfaei R, Salesi M, Izadi M, Raei M. Rate, risk factors, and clinical outcomes of SARS-CoV-2 reinfection vs. primary infection in readmitted COVID-19 patients in Iran: a retrospective cohort study Frontiers in public health 12:1480805 2024 [PMID: 39484354]
206. Faherty LJ, Nascimento de Lima P, Lim JZ, Roberts D, Karr S, Lawson E, Willis HH. Effects of non-pharmaceutical interventions on COVID-19 transmission: rapid review of evidence from Italy, the United States, the United Kingdom, and China Frontiers in public health 12:1426992 2024 [PMID: 39484353]
207. Meseko C, Sanicas M, Gupta Y, Kumar B. Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches Frontiers in cellular and infection microbiology 14:1497018 2024 [PMID: 39483121]
208. Belviranli S, Oltulu R, Mirza E, Adam M, Gundogan AO. Can Inactivated Coronavirus Disease 2019 Vaccine Cause Bilateral Neurotrophic Keratopathy? Journal of current ophthalmology 36(1):99-9102 2024 [PMID: 39553326]
209. Okeke KI, Ahamefule CS, Nnabuife OO, Orabueze IN, Iroegbu CU, Egbe KA, Ike AC. Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases Current research in microbial sciences 7:100293 2024 [PMID: 39497935]
210. Keshtkar-Jahromi M, Adam SJ, Brar I, Chung LK, Currier JS, Daar ES, Davey VJ, Denning ET, Gelijns AC, Higgs ES, Jagannathan P, Javan AC, Jensen TO, Jilg N, Kalomenidis I, Kim P, Nayak SU, Newell M, Taiwo BO, Yokum T, Delph Y. ACTIV trials: cross-trial lessons learned for master protocol implementation Journal of clinical and translational science 8(1):e152 2024 [PMID: 39540114]
211. Lim RJ, Qiu X, Leong RN, Gutierrez JL, Halima A, Mostafa M, Ghoneim Y, Abdrabo M, Rashad M, Hannawi S, Liu Y, Mojares Z. Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial Clinical and experimental vaccine research 13(4):315-328 2024 [PMID: 39525677]
212. Hamijoyo L, Philo P, Nathan DS, Tiara MR, Mardiana SR, Susandi E, Ghassani NG, Alisjahbana B. Anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain antibody levels in patients with systemic lupus erythematosus based on vaccination status and related factors in Indonesia Clinical and experimental vaccine research 13(4):348-358 2024 [PMID: 39525676]
213. Jirawattanadon P, Leeyaphan C, Koomanachai P, Pudchakan P, Bunyaratavej S, Kulthanan K, Tuchinda P, Hutachoke T, Nanchaipruek Y, Phumariyapong P. Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination Clinical and experimental vaccine research 13(4):309-314 2024 [PMID: 39525675]
214. Iqbal S, Qudah T, Ali I, Abid J, Ahmad AMR. COVID-19 vaccine hesitancy among medical students, health professionals, and health care workers: an umbrella review Clinical and experimental vaccine research 13(4):263-270 2024 [PMID: 39525674]
215. Lim RJ, Qiu X, Alberto E, Capeding MR, Carlos J, Leong RN, Gutierrez JL, Trillana M, Liu Y, Mojares Z. Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study Clinical and experimental vaccine research 13(4):329-337 2024 [PMID: 39525672]
216. Aghsami M, Aljoiber H, Mirfendereski S, Mottaghi-Dastjerdi N, Soltani J, Aslani H, Shariatpanahi M. Effect of SpikoGen subunit vaccine administration during pregnancy on fetal development of rats Clinical and experimental vaccine research 13(4):301-308 2024 [PMID: 39525669]
217. Bolormaa E, Shim J, Choi YS, Kwon D, Choe YJ, Choe SA. Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review Osong public health and research perspectives 15(5):395-408 2024 [PMID: 39511961]
218. Altynbekova S, Abylaiuly Z, Bolshakova S, Davlyatshin T, Aimakhanova A. Post-COVID syndrome and type 2 diabetes mellitus in Kazakhstan: clinical manifestations and vaccine efficacy Annals of pediatric endocrinology & metabolism 29(5):325-336 2024 [PMID: 39506346]
219. Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Murri R, Zvirbulis V, Zavadska D, Gaio V, Popescu CP, Hrisca R, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, De Gaetano Donati K, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Santangelo R, Krievins D, Barzdina EA, Valadas Henriques C, Kosa AG, Pohrib SM, Muñoz-Almagro C, Milagro A, Bacci S, Nardone A. Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(44) 2024 [PMID: 39484687]
220. Wan Z, Han J, Wang D, Li Y, Zhai W, Zhao W, Zhang X, Xie Y. Effects of vaccination on antibody level and duration of viral shedding in Omicron patients Journal of infection in developing countries 18(9.1):S184-S190 2024 [PMID: 39499763]
221. Chavarría-Bencomo IV, Chavez-Trillo C, López-Quiñonez MG, Adame-Gallegos JR, Zurawski S, Espino-Solis GP, Zurawski G. Monitoring humoral responses against three SARS-CoV-2 vaccines in a university population from Chihuahua, Mexico Journal of infection in developing countries 18(9.1):S135-S146 2024 [PMID: 39499757]
222. García-Moncada E, Cortés-Ortíz IA, Quijano-Soriano MF, Nolasco-Rojas AE, Chávez-Ocaña S, Loyola-Cruz MÁ, Ramírez-Hernández MDC, Calzada-Mendoza CC, Victoria-Acosta G, Gomez-Zamora E, Bravata-Alcántara JC, Bello-López JM. Epidemiology of reinfections by SARS-CoV-2 variants during the third and fourth waves of the COVID-19 pandemic Journal of infection in developing countries 18(9.1):S126-S134 2024 [PMID: 39499756]
223. Hacıseyitoğlu D, Yılmaz Ş, Erdoğan F, Cömert F. Stability of SARS-CoV-2 antibody in serum under various usage and storage conditions Journal of infection in developing countries 18(9.1):S101-S106 2024 [PMID: 39499753]
224. Dai Q, Bao C, Ju H, Li N, Wang S, Wen J, Zhou Q, Chen L, Chen Y, Xu L, Zhou X, Ding S, Hu J, Zhu F. Analysis of re-infection cases and influencing factors post first severe COVID-19 wave in Jiangsu Province, China Journal of infection in developing countries 18(9.1):S92-S100 2024 [PMID: 39499752]
225. Hamid U, Pitton Rissardo J, Alviz LF, Fornari Caprara AL, Franada TS. Myelin Oligodendrocyte Glycoprotein G Antibody-Positive Paraneoplastic Myelopathy in Seminoma: A Case Report and Literature Review The Neurohospitalist :19418744241288288 2024 [PMID: 39544263]
226. Shirzad-Yazdi N, Namdari N, Noorani A, Karimzadeh I. Is there a Possible Association between Multiple Myeloma Relapse and Coronavirus Disease 2019 Vaccination? A Case Report Journal of research in pharmacy practice 13(1):27-32 2024 [PMID: 39483994]
227. Okada Y, Nishiura H. Vaccine-induced reduction of COVID-19 clusters in school settings in Japan during the epidemic wave caused by B.1.1.529 (Omicron) BA.2, 2022 Mathematical biosciences and engineering : MBE 21(9):7087-7101 2024 [PMID: 39483074]
228. de Guzman JCC, Dulay ANG, Orosco FL. Selective protease inhibitors from secondary metabolites of Philippine medicinal plants against porcine epidemic diarrhea virus: A computational veterinary drug discovery approach Open veterinary journal 14(9):2192-2214 2024 [PMID: 39553769]
229. Mori M, Omae Y, Kakimoto Y, Sasaki M, Toyotani J. Analyzing factors of daily travel distances in Japan during the COVID-19 pandemic Mathematical biosciences and engineering : MBE 21(8):6936-6974 2024 [PMID: 39483101]
230. Morciglio A, Zia RKP, Hyman JM, Jiang Y. Understanding the oscillations of an epidemic due to vaccine hesitancy Mathematical biosciences and engineering : MBE 21(8):6829-6846 2024 [PMID: 39483095]
231. Kreabkhontho P, Teparos W, Theparod T. Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach Mathematical biosciences and engineering : MBE 21(8):6807-6828 2024 [PMID: 39483094]
232. Kleinhans I, Mahanjana S, Els F, Mabona M, Pitso LA, Malatje G, Kok G, Raman J. The prevalence and distribution of malaria in Mpumalanga Province before and during COVID-19 (2017 - 2022) South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(8):e1736 2024 [PMID: 39508196]
233. Ullah MF, Alnour TM, Ahmed Abakur EH, Elssaig EH, Saeedi NH. In-depth genomic characterisation of SARS-CoV-2 variants from Egypt exhibited heterogeneous lineages Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 30(7):481-491 2024 [PMID: 39548837]
234. Mortaz E, Dalil Roofchayee N, Jamaati H, Varaham M, Abtahian Z, Afshar B, Rekabi M, Adcock IM, Tabarsi P. Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review Iranian journal of allergy, asthma, and immunology 23(4):457-466 2024 [PMID: 39549298]
235. Noreen N, Bashir F, Afzal S, Khan NU, Ghafoor T. Ethics challenges in implementing the International Health Regulations in Pakistan during the COVID-19 pandemic Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 30(6):404-413 2024 [PMID: 39545290]
236. Kouassi KS, Chisupa E, Clarke A, Massenon I, Miano C, Mutuku F, Wanyoike S, Mumba M, Diouf R, Morgan C, Jennings MC. Pandemic-related resilience in HPV vaccination programmes - Perspectives from selected countries in Africa on what it will take to vaccinate 90 % of girls by 2030 Vaccine 42 Suppl 2:S33-S36 2024 [PMID: 39521569]
237. Balay-Odao EM, Danglipen CC, Caballes LG. Behind Coronavirus Disease 2019 Vaccine Hesitancy of Filipino Nurses: A Thematic Approach Florence Nightingale journal of nursing 32(1):17-23 2024 [PMID: 39552329]
238. Huynh A, Shaw S, Lazarus L, Marcelino D, Lorway R. Commentary: COVID-19 healthcare barriers around vaccine uptake among migrant workers within the Canadian Prairies Global public health 19(1):2426133 2024 [PMID: 39541428]
239. Reynard C, Campling J, Gordon AL, Kassianos G, Liu HH, Richter A, Vyse A, Wiseman DJ, Wright H, Ellsbury G. Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment Expert review of vaccines 23(1):1052-1067 2024 [PMID: 39540854]
240. Rizzuto JL, Pyne AS, Gatta LA. Caring for Pregnant Patients by Including Pregnant Participants The Journal of clinical ethics 35(4):284-287 2024 [PMID: 39540643]
241. Muehleman D, Gruner B, Hogan V, Fanning P, Garrett C, Meyer J, Lanter K, Purves S, DeMarcus L, Thervil J, Kwaah B, Sjoberg P, Macias E, Fries A. Using SARS-CoV-2 Sequencing Data to Identify Reinfection Cases in the Global Emerging Infections Surveillance Program, United States Emerging infectious diseases 30(14):53-61 2024 [PMID: 39530855]
242. Siddiqui MK, Taqi M, Yaqoob R, Aslam AM, Razak HS. Responses of health professionals to coronavirus, coronavirus variants, and vaccines: Cross-sectional study Work (Reading, Mass.) 79(3):1379-1389 2024 [PMID: 39520162]
243. Yektadoust E, Janghorbani A, Talebi AF. XCNN-SC: Explainable CNN for SARS-CoV-2 variants classification and mutation detection Computers in biology and medicine 167:107606 2023 [PMID: 39491375]

Coxiella burnetii (Q fever)

1. Esmaeili H, Ghorani M, Hamidiya Z, Joghataei SM, Villanueva-Saz S, Lacasta D. Causes of abortion in Iranian goat herds and associated risk factors Preventive veterinary medicine 234:106381 2024 [PMID: 39536431]
2. Meles DK, Khairullah AR, Mustofa I, Wurlina W, Akintunde AO, Suwasanti N, Mustofa RI, Putra SW, Moses IB, Kusala MKJ, Raissa R, Fauzia KA, Aryaloka S, Fauziah I, Yanestria SM, Wibowo S. Navigating Q fever: Current perspectives and challenges in outbreak preparedness Open veterinary journal 14(10):2509-2524 2024 [PMID: 39545195]

Ebola virus

1. Marx de Andrade R, Paulos A, Valadas E, Laerte Pinto Junior V. [Disease Caused by Filoviruses: An Update] Acta medica portuguesa 2024 [PMID: 39566016]
2. Kuehn R, Ryan H, Okwaraeke KC, Gould S, Chaplin M, Riley M, Turtle L, Jacob ST, Fletcher T. Vaccines for preventing Ebola virus disease The Cochrane database of systematic reviews 11(11):CD015828 2024 [PMID: 39560047]
3. Valayer S, Alexandre M, Prague M, Beavogui AH, Doumbia S, Kieh M, Greenwood B, Leigh B, Poupelin M, Schwimmer C, Sow SO, Berry IM, Kuhn JH, Fusco D, Cauwelaert ND, Watson-Jones D, Thiébaut R, Lévy Y, Yazdanpanah Y, Richert L, Lhomme E. Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial Emerging microbes & infections :2432353 2024 [PMID: 39559990]
4. Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM. rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches) BMC medicine 22(1):523 2024 [PMID: 39511527]
5. Nosaka T, Ohtsuka J, Ohtsuka T, Fukumura M. Next Generation RNA/Protein-Carrying Vector With Pleiotropic Activity Reviews in medical virology 34(6):e70008 2024 [PMID: 39488720]
6. Ssetaala A, Welsh S, Nakaweesa T, Wambuzi M, Nanyonjo G, Nanvubya A, Mpendo J, Nalutaaya A, Ssempiira J, Nielsen L, Fast P, Price M, Kiwanuka N. Healthcare use and sexually transmitted infections treatment-seeking: a mixed methods cross-sectional survey among hard-to-reach fishing communities of Lake Victoria, Uganda The Pan African medical journal 48:134 2024 [PMID: 39554263]

Escherichia coli

1. Zhu W, Chen M, Zhang X, Su J, Zhang X, Nong Y, Wang B, Guo W, Xue Y, Wang D, Liao Y, Niu J, Hong Y, Drlica K, Zhao X. Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source mSphere :e0077224 2024 [PMID: 39565127]
2. Azam AH, Kondo K, Chihara K, Nakamura T, Ojima S, Nie W, Tamura A, Yamashita W, Sugawara Y, Sugai M, Cui L, Takahashi Y, Watashi K, Kiga K. Evasion of antiviral bacterial immunity by phage tRNAs Nature communications 15(1):9586 2024 [PMID: 39528469]
3. Mahtab S, Madewell ZJ, Baillie V, Dangor Z, Lala SG, Assefa N, Berihun M, Madrid L, Regassa LD, Scott JAG, Ameh S, Bangura JS, Ita O, Kaluma E, Ogbuanu IU, Gaume B, Kotloff KL, Sow SO, Tapia MD, Ajanovic S, Garrine M, Mandomando I, Varo R, Xerinda EG, Alam M, El Arifeen S, Gurley ES, Hossain MZ, Rahman A, Akelo V, Igunza KA, Onyango C, Onyango D, Verani JR, Mutevedzi P, Whitney CG, Blau DM, Madhi SA, Bassat Q. Etiologies and comorbidities of meningitis deaths in children under 5 years in high-mortality settings: Insights from the CHAMPS Network in the post-pneumococcal vaccine era The Journal of infection 89(6):106341 2024 [PMID: 39521254]
4. Chowdhury S, Sadhukhan P, Mahata N. Immunoinformatics investigation on pathogenic Escherichia coli proteome to develop an epitope-based peptide vaccine candidate Molecular diversity 2024 [PMID: 39516450]
5. Tanaka R, Tamao K, Ono M, Yamayoshi S, Kawaoka Y, Su'etsugu M, Noji H, Tabata KV. In vitro one-pot construction of influenza viral genomes for virus particle synthesis based on reverse genetics system PloS one 19(11):e0312776 2024 [PMID: 39514509]
6. Ahmed N, Rani NA, Robin TB, Mashrur MN, Shovo MMI, Prome AA, Sultana S, Nazneen Akhand MR. Designing a multi-epitope subunit vaccine against Toxoplasma gondii through reverse vaccinology approach Molecular and biochemical parasitology 260:111655 2024 [PMID: 39521441]
7. Fang T, Xiong J, Huang X, Fang X, Shen X, Jiang Y, Lu H. Extracellular Hsp90 of Candida albicans contributes to the virulence of the pathogen by activating the NF-κB signaling pathway and inducing macrophage pyroptosis Microbiological research 290:127964 2024 [PMID: 39522202]
8. Ma Z, Li Z, Yang T, Zhao X, Zheng C, Li Y, Li Y, Guo X, Xu L, Zheng Z, Zheng H, Xiao S. A cell-penetrating NS5B-specific nanobody inhibits bovine viral diarrhea virus replication Microbial pathogenesis 197:107107 2024 [PMID: 39510363]
9. Zhang H, Liu Z, Li Y, Tao Z, Shen L, Shang Y, Huang X, Liu Q. Adjuvants for Helicobacter pylori vaccines: Outer membrane vesicles provide an alternative strategy Virulence :2425773 2024 [PMID: 39501551]
10. Jones A, Ahmed SM, Platts-Mills JA, Kotloff KL, Levine AC, Nelson EJ, Pavia AT, Khan AI, Leung DT. Etiology of Severely Dehydrating Diarrheal Illness in Infants and Young Children Residing in Low- and Middle-Income Countries Open forum infectious diseases 11(11):ofae619 2024 [PMID: 39494449]
11. Mozafari A, Rahmani M, Yasini Nasab Y, Shahsavandi S, Jafari M, Salmanian AH. The heterologous expression of novel recombinant protein composed of HN and F moieties of Newcastle disease virus and immunogenicity evaluation in mouse model Iranian journal of microbiology 16(5):655-665 2024 [PMID: 39534294]

Hantavirus

1. Hooper JW, Kwilas SA, Josleyn M, Norris S, Hutter JN, Hamer M, Livezey J, Paolino K, Twomey P, Koren M, Keiser P, Moon JE, Nwaeze U, Koontz J, Ledesma-Feliciano C, Landry N, Wellington T. Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection NPJ vaccines 9(1):221 2024 [PMID: 39551791]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

1. Bertini CD Jr, Khawaja F, Sheshadri A. Coronavirus Disease-2019 in the Immunocompromised Host Rheumatic diseases clinics of North America 51(1):123-138 2025 [PMID: 39550101]
2. Kamara MS, Kwakye G. Prevention of Anal Cancer Surgical oncology clinics of North America 34(1):49-58 2025 [PMID: 39547768]
3. Abi Aad Y, Ballouz T, Faysal H, Mahfouz R, Shabb N, Sader G, El-Helou R, Doughan S, Rizk NA. Prevalence of human papilloma virus infection and anal dysplasia among men with HIV in Lebanon: a cross-sectional study HIV research & clinical practice 25(1):2425548 2024 [PMID: 39508511]
4. Karthigeyan KP, Binuya C, Vuong K, Permar SR, Nelson AN. Research on Maternal Vaccination for HIV Prevention Clinics in perinatology 51(4):769-782 2024 [PMID: 39487019]
5. Wang N, Fan H, Wang Y, Shu C, Lin Q, Hu P, Wang N, Zhang D. The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthrough infection Life sciences 358:123197 2024 [PMID: 39481835]
6. Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L, Marras TK, Rea E, Kwong JC, Campitelli MA, Campbell JR, Schwartzman K, Cook VJ, Johnston JC. Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 [PMID: 39561254]
7. Mullen D, Edney J, Phillips D, Wilkie R, Reid D, Lowndes CM, Buitendam E, Sinka K, Mandal S, Mercer CH, Saunders J, Mohammed H, Ogaz D. Mpox vaccination uptake in a UK community sample of gay, bisexual and other men who have sex with men (GBMSM) the year following the 2022 clade IIb mpox outbreak Sexually transmitted infections 2024 [PMID: 39567005]
8. Etuk VP, Sanni C, Omonijo O, Atema SI, Lawal T, Yashim-Ankut AM, Ejinkeonye I, Onyegbutulem HC, Oyedele OK, Williams I, Andrew NP, Okpokoro E. Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria Transactions of the Royal Society of Tropical Medicine and Hygiene 2024 [PMID: 39558837]
9. Naicker N, Osman F, Naidoo K, Bodley N, Mbambo N, Madlala S, Mhlongo T, Mbatha N, Maphumulo A, Munatsi P, Radebe P, Liebenberg L, Dorward J, Drain PK, Garrett N. High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa Sexually transmitted infections 2024 [PMID: 39557497]
10. Liu H, Zou M, Shen M, Kamarulzaman A, Chen S, Li J, Li R, Liu H, Zou Z, Zhang L. HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis International journal of cancer 2024 [PMID: 39551969]
11. Sadat SM, Jahedian S, Sabaghzadeh S, Larijani MS, Bolhassani A. Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen Protein and peptide letters 2024 [PMID: 39558498]
12. Masooma, Qaiser A, Ali DS, Manzoor DS. Prospects of Carica papaya in the treatment of human viral infections: A comprehensive and a systematic review Heliyon 10(21):e39635 2024 [PMID: 39553635]
13. Fashina OA, Chuang TM, Galardy PJ, Huskins WC, Levy ER, Streck NT, Chakraborty R. Disseminated vaccine-strain varicella-zoster virus reactivation in an adolescent with secondary immunodeficiency: a case report and literature review BMC infectious diseases 24(1):1296 2024 [PMID: 39543470]
14. Cohen C, du Plessis M, Martinson N, Moyes J, Walaza S, Wolter N, Makhasi M, Moosa F, Charles M, Samuels AM, Tempia S, Moloantoa T, Ncwana B, Phalatse L, Buys A, Fry A, Baumgartner EA, von Gottberg A, Kleynhans J. A potential platform for future vaccine trials identifies high incidence of symptomatic and asymptomatic influenza infection among children aged 6-23 months in South Africa The Journal of infectious diseases 2024 [PMID: 39542652]
15. Ondondo RO, Muthusi J, Oramisi V, Kimani D, Ochwoto M, Young P, Ngugi C, Waruru A, Mwangi J, Chao A, Bronson M, Dobbs T, Ng'ang'a L, Bowen N, Aoko A, Armstrong PA, Aman R, Bulterys M. Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018 PloS one 19(11):e0310923 2024 [PMID: 39541401]
16. Namwat C, Leela-Apiradee W, Tiawilai T, Dear N, Wansom T, Kitsiripornchai S, Premsri N, Akapirat S, Crowell TA, Francisco L, Li Q, Robb ML, Smith KS, Heger EA, Fukuda MM, O'Connell RJ, Rerks-Ngarm S, Vasan S. Prospective longitudinal study of men who have sex with men and transgender women to determine HIV incidence in two provinces in Thailand PloS one 19(11):e0309355 2024 [PMID: 39541303]
17. Bazrafshani MS, Mehmandoost S, Tavakoli F, Shahesmaeili A, Ghalekhani N, Sharafi H, SeyedAlinaghi S, Haghdoost A, Karamouzian M, Sharifi H. Self-reported lifetime Hepatitis B virus testing, and vaccination uptake among people who inject drugs in Iran: a nationwide study in 2020 BMC public health 24(1):3156 2024 [PMID: 39538214]
18. Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial Nature communications 15(1):9785 2024 [PMID: 39532861]
19. Gilmore J, Comer D, Field DJ, Parlour R, Shanley A, Noone C. Recognising and responding to the community needs of gay and bisexual men around mpox PloS one 19(11):e0313325 2024 [PMID: 39531450]
20. Dankwa S, Kosman C, Dennis M, Giorgi EE, Vuong K, Pahountis I, Garza A, Binuya C, McCarthy J, Mayer BT, Ngo JT, Enemuo CA, Carnathan DG, Stanfield-Oakley S, Berendam SJ, Weinbaum C, Engelman K, Magnani DM, Chan C, Ferrari G, Silvestri G, Amara RR, Chahroudi A, Permar SR, Fouda GG, Goswami R. A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions PloS one 19(11):e0312411 2024 [PMID: 39527587]
21. Thomas K, Danso M, Goddard G, Maydoilis HD, Oguche SM, Bello T, Njoku CH, Obiako OR. A RARE CASE OF MIXED CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY (CIDP) AND ACUTE TRANSVERSE MYELITIS (ATM) West African journal of medicine 41(11 Suppl 1):S29 2024 [PMID: 39540301]
22. Antonova AA, Lebedev AV, Ozhmegova EN, Shlykova AV, Lapavok IA, Kuznetsova AI. Variability of non-structural proteins of HIV-1 sub-subtype A6 (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1, sub-subtype A6) variants circulating in different regions of the Russian Federation Voprosy virusologii 69(5):470-480 2024 [PMID: 39527769]
23. Bobkova MR. Defective HIV proviruses: possible involvement in the HIV infection pathogenesis Voprosy virusologii 69(5):399-414 2024 [PMID: 39527763]
24. Naidoo D, Govender K, Mantell JE. Breaking barriers: why including boys and men is key to HPV prevention BMC medicine 22(1):525 2024 [PMID: 39516809]
25. Sun C, Li Y, Marini S, Riva A, Wu DO, Fang R, Salemi M, Rife Magalis B. Phylogenetic-informed graph deep learning to classify dynamic transmission clusters in infectious disease epidemics Bioinformatics advances 4(1):vbae158 2024 [PMID: 39529841]
26. Raza SZ, Masood T, Akram M. Unearthing Influenza's Unusual Neurological Impact Cureus 16(11):e73203 2024 [PMID: 39512806]
27. Han X, Wang X, Han F, Yan H, Sun J, Zhang X, Moog C, Zhang C, Su B. The cGAS-STING pathway in HIV-1 and Mycobacterium tuberculosis coinfection Infection 2024 [PMID: 39509013]
28. Ding H, Nguyen HT, Li W, Deshpande A, Zhang S, Jiang F, Zhang Z, Anang S, Mothes W, Sodroski J, Kappes JC. Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation Journal of virology :e0172024 2024 [PMID: 39508605]
29. Babcock BR, Kosters A, Eddins DJ, Donaire MSB, Sarvadhavabhatla S, Pae V, Beltran F, Murray VW, Gill G, Xie G, Dobosh BS, Giacalone VD, Tirouvanziam RM, Ramonell RP, Jenks SA, Sanz I, Lee FE, Roan NR, Lee SA, Ghosn EEB. Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19 Science translational medicine 16(772):eadq1789 2024 [PMID: 39504354]
30. Lucinde RK, Gathuri H, Isaaka L, Ogero M, Mumelo L, Kimego D, Mbevi G, Wanyama C, Otieno EO, Mwakio S, Saisi M, Isinde E, Oginga IN, Wachira A, Manuthu E, Kariuki H, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi D, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Ahmed N, Gituma B, Giabe M, Omondi C, Aman R, Amoth P, Kasera K, Were F, Nganga W, Berkley JA, Tsofa B, Mwangangi J, Bejon P, Barasa E, English M, Scott JAG, Akech S, Kagucia EW, Agweyu A, Etyang AO. Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic BMC infectious diseases 24(1):1246 2024 [PMID: 39501217]
31. Friedman MR, Wingood G, Krause KD, Krier S, D'souza G, Kempf MC, Mimiaga MJ, Kwait J, Jones D, Martinson J, Marques ET, Tien P, Anastos K, Ramirez C, Cohen M, Camacho-Rivera M, Goparaju L, Rinaldo CR. Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort AIDS (London, England) 2024 [PMID: 39497542]
32. Hasso-Agopsowicz M, Hwang A, Hollm-Delgado MG, Umbelino-Walker I, Karron RA, Rao R, Asante KP, Sheel M, Sparrow E, Giersing B. Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030 EBioMedicine :105424 2024 [PMID: 39500705]
33. Raccagni AR, Diotallevi S, Lolatto R, Bruzzesi E, Martearena Garcia MDC, Mainardi I, Candela C, Canetti D, Piromalli G, Clementi N, Burioni R, Castagna A, Nozza S. Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features Open forum infectious diseases 11(11):ofae562 2024 [PMID: 39498171]
34. Henderson R, Anasti K, Manne K, Stalls V, Saunders C, Bililign Y, Williams A, Bubphamala P, Montani M, Kachhap S, Li J, Jaing C, Newman A, Cain DW, Lu X, Venkatayogi S, Berry M, Wagh K, Korber B, Saunders KO, Tian M, Alt F, Wiehe K, Acharya P, Alam SM, Haynes BF. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies Nature communications 15(1):9503 2024 [PMID: 39489734]
35. Delany-Moretlwe S, Machalek DA, Travill D, Petoumenos K, Nyemba DC, Mbulawa ZZA, Ndlovu N, Kaldor JM, Rees H. Impact of single-dose HPV vaccination on HPV 16 and 18 prevalence in South African adolescent girls with and without HIV Journal of the National Cancer Institute. Monographs 2024(67):337-345 2024 [PMID: 39529527]
36. Deng E, Craig TJ, Nguyen DV, Al-Shaikhly T. COVID-19 and severe cutaneous allergic reactions to sulfonamides Allergy and asthma proceedings 45(6):e93-e100 2024 [PMID: 39517080]
37. Brandl M, Schmidt AJ, Marcus U, Duffell E, Severi E, Mozalevskis A, Kivite-Urtane A, An der Heiden M, Dudareva S. Self-reported hepatitis A and B vaccination coverage among men who have sex with men (MSM), associated factors and vaccination recommendations in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(45) 2024 [PMID: 39512170]
38. Burdi S, Brandl M, Marcus U, Duffell E, Severi E, Mozalevskis A, Rüütel K, Dörre A, Schmidt AJ, Dudareva S. Viral hepatitis knowledge and vaccination awareness among men who have sex with men (MSM) in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(45) 2024 [PMID: 39512166]
39. Obeagu EI, Obeagu GU, Akinleye CA. Unveiling the enigmatic roles of basophils in HIV infection: A narrative review Medicine 103(44):e40384 2024 [PMID: 39496030]
40. Hohn O, Meixenberger K, Volkwein A, Körner K, Icli S, Koppe U, Hower M, Bremer V, Gunsenheimer-Bartmeyer B, Bannert N. SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020-2022 BMC infectious diseases 24(1):1228 2024 [PMID: 39487409]
41. Orya EE, Akume CM, Atobatele S, Sampson S, Envuladu EA, Okagbue HI. The effect of participatory action research on HPV primary preventive measures among in-school adolescents in Benue State, Nigeria BMC public health 24(1):3033 2024 [PMID: 39487403]
42. Obeid D, Alsuwairi F, Alnemari R, Al-Qahtani A, Kurdi W, Alfareh M, Alsanea M, Alabdulkareem M, Alharbi L, Alhamlan FS. Sexually transmitted infections in the middle east and North Africa: comprehensive systematic review and meta-analysis BMC infectious diseases 24(1):1229 2024 [PMID: 39487391]
43. Karenna N, Bryan B. Focused learning by antibody language models using preferential masking of non-templated regions bioRxiv : the preprint server for biology 2024 [PMID: 39553994]
44. Stupak A, Kwiatek M, Gęca T, Kwaśniewska A, Mlak R, Nawrot R, Goździcka-Józefiak A, Kwaśniewski W. A Virome and Proteomic Analysis of Placental Microbiota in Pregnancies with and without Fetal Growth Restriction Cells 13(21) 2024 [PMID: 39513860]
45. Cho SY, Kim KD, Shin CG. Advances in foamy virus vector systems: Development and applications Virology 601:110270 2024 [PMID: 39509861]
46. Rosen BC, Sawatzki K, Ricciardi MJ, Smith E, Golez I, Mauter JT, Pedreño-López N, Yrizarry-Medina A, Weisgrau KL, Vosler LJ, Voigt TB, Louw JJ, Tisoncik-Go J, Whitmore LS, Panayiotou C, Ghosh N, Furlott JR, Parks CL, Desrosiers RC, Lifson JD, Rakasz EG, Watkins DI, Gale M Jr. Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control Frontiers in immunology 15:1478063 2024 [PMID: 39502699]
47. Ballow M, Ortiz-de-Lejarazu R, Quinti I, Miller MS, Warnatz K. Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy Frontiers in immunology 15:1452106 2024 [PMID: 39502688]
48. Cleary M, Ndhlovu LC, Sacha JB. Stem cell transplantation and allogeneic immunity: post treatment control or HIV cure? Current opinion in HIV and AIDS 2024 [PMID: 39484913]
49. Violari A, Otwombe K, Hahn W, Chen S, Josipovic D, Baba V, Angelidou A, Smolen KK, Levy O, Mkhize NN, Woodward AS, Martin TM, Haynes B, Williams WB, Sagawa ZK, Kublin J, Polakowski L, Isaacs MB, Yen C, Tomaras G, Corey L, Janes H, Gray G. Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns medRxiv : the preprint server for health sciences 2024 [PMID: 39484284]
50. Keshtkar-Jahromi M, Adam SJ, Brar I, Chung LK, Currier JS, Daar ES, Davey VJ, Denning ET, Gelijns AC, Higgs ES, Jagannathan P, Javan AC, Jensen TO, Jilg N, Kalomenidis I, Kim P, Nayak SU, Newell M, Taiwo BO, Yokum T, Delph Y. ACTIV trials: cross-trial lessons learned for master protocol implementation Journal of clinical and translational science 8(1):e152 2024 [PMID: 39540114]
51. Wohl DA, Adam SJ, Gibbs KW, Moskowitz AL, Ortel TL, Singh U, Jilg N, Evering TH, Fischer WA 2nd, Taiwo BO, Daar ES, Lindsell CJ, Naggie S, Rothman RL, Dunsmore SE, McAdams MP, Vail J, Jayaweera D. Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative Journal of clinical and translational science 8(1):e156 2024 [PMID: 39540112]
52. Zimmerman RS, Wonderly K, Abdul-Kadr H, DiClemente RJ, Turner MM, Xu M, Rosenberger JG. Assessing the Importance of Theory-Based Correlates of Future HIV Vaccine Intentions Among Black Men Who Have Sex With Men AIDS education and prevention : official publication of the International Society for AIDS Education 36(5):354-369 2024 [PMID: 39509256]
53. Datta M, Yasmin S, Biswas R. Immunization Status, Immunization Coverage, and Factors Associated with Immunization Service Utilization Among HIV-Exposed and HIV-Infected Children in India International journal of MCH and AIDS 13:e021 2024 [PMID: 39526167]
54. Brink A, Kgasi A, Musyoki A, Kagina B, Feldman C, Reddy D, Du Toit E, Kalanxhi E, Meyer J, Impalli I, Schönfeldt M, Sibanda M, Schellack N, Skosana P, Essack S, Dlamini S, Ramsamy Y. Vaccines in the fight against antimicrobial resistance - perspectives from South Africa South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(9):e2111 2024 [PMID: 39513247]
55. Dangor Z, Birkhead M, Verwey C, Gray D, Vanker A, Githinji L, Goga A, Masekela R, Zampoli M. Primary ciliary dyskinesia: Meeting the challenges of diagnosis in South Africa South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(8):e2269 2024 [PMID: 39508191]
56. Mortaz E, Dalil Roofchayee N, Jamaati H, Varaham M, Abtahian Z, Afshar B, Rekabi M, Adcock IM, Tabarsi P. Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review Iranian journal of allergy, asthma, and immunology 23(4):457-466 2024 [PMID: 39549298]
57. Ssetaala A, Welsh S, Nakaweesa T, Wambuzi M, Nanyonjo G, Nanvubya A, Mpendo J, Nalutaaya A, Ssempiira J, Nielsen L, Fast P, Price M, Kiwanuka N. Healthcare use and sexually transmitted infections treatment-seeking: a mixed methods cross-sectional survey among hard-to-reach fishing communities of Lake Victoria, Uganda The Pan African medical journal 48:134 2024 [PMID: 39554263]

Lassa virus

1. Carey BD, Yu S, Geiger J, Ye C, Huzella LM, Reeder RJ, Mehta M, Hirsch S, Bernbaum R, Cubitt B, Pahar B, Anthony SM, Marketon A, Bernbaum JG, Tran JP, Crozier I, Martínez-Sobrido L, Worwa G, de la Torre JC, Kuhn JH. A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs NPJ vaccines 9(1):220 2024 [PMID: 39551823]
2. Şimşek H, Gül Ş. Discovering Lassa virus nucleoprotein inhibitors via in silico drug repositioning approach Journal of biomolecular structure & dynamics :1-21 2024 [PMID: 39533921]
3. Dutuze MF, Clark SD, Del Piero F, Christofferson RC. Preliminary evidence that Bunyamwera virus causes severe disease characterized by systemic vascular and multiorgan necrosis in an immunocompromised mouse model The Journal of general virology 105(11) 2024 [PMID: 39503743]
4. Chaudhary M, Cutland CL, Bonet M, Gentile A, Jones CE, Marshall HS, Stergachis A, Voss G, Darko DM, Sevene E, Hyde T, Fairlie L, Kampmann B, Everett D, Munoz FM. Burden of Lassa fever disease in pregnant women and children and options for prevention Vaccine 43(Pt 1):126479 2024 [PMID: 39488189]
5. Antonelli R, Forconi V, Molesti E, Semplici C, Piu P, Altamura M, Dapporto F, Temperton N, Montomoli E, Manenti A. A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison F1000Research 13:534 2024 [PMID: 39512237]

Marburg virus

1. Marx de Andrade R, Paulos A, Valadas E, Laerte Pinto Junior V. [Disease Caused by Filoviruses: An Update] Acta medica portuguesa 2024 [PMID: 39566016]
2. Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM. rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches) BMC medicine 22(1):523 2024 [PMID: 39511527]
3. Firew T, Mwiseneza L, Asabwe M, Vanessa IN, Uwintwari MH, Nizeyimana F, Uwamahoro DL. Women at the front line of the Marburg virus disease response in Rwanda: balancing clinical care, public health, and family life The Lancet. Global health 2024 [PMID: 39510103]

Mycobacterium tuberculosis (tuberculosis)

1. Gulumbe BH, Abdulrahim A, Danlami MB. The United Nations' ambitious roadmap against tuberculosis: opportunities, challenges and the imperative of equity Future science OA 10(1):2418787 2024 [PMID: 39539153]
2. Moolla N, Weaver H, Bailo R, Singh A, Bavro VN, Bhatt A. The role of ABC transporter DrrABC in the export of PDIM in Mycobacterium tuberculosis Cell surface (Amsterdam, Netherlands) 12:100132 2024 [PMID: 39507394]
3. Peralta-Álvarez MP, Downward K, White A, Redondo Azema H, Sibley L, Sarfas C, Morrison A, Dennis M, Diaz-Santana D, Harris SA, Li S, Puentes E, Aguilo N, Martin C, Sharpe S, McShane H, Tanner R. MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates NPJ vaccines 9(1):230 2024 [PMID: 39567530]
4. Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L, Marras TK, Rea E, Kwong JC, Campitelli MA, Campbell JR, Schwartzman K, Cook VJ, Johnston JC. Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 [PMID: 39561254]
5. Yu S, Zhan M, Li K, Chen Q, Liu Q, Gavotte L, Frutos R, Chen T. Analysis of Tuberculosis Epidemiological Distribution Characteristics in Fujian Province, China, 2005-2021: Spatial-Temporal Analysis Study JMIR public health and surveillance 10:e49123 2024 [PMID: 39556716]
6. Nandi TR, Saha AK, Roy S. Analysis of a fractional order epidemiological model for tuberculosis transmission with vaccination and reinfection Scientific reports 14(1):28290 2024 [PMID: 39550369]
7. Lehyen DB, Ako-Egbe L, Dwalu E, Vonhm BT, Thekkur P, Zachariah R, Bawo L. Health care workers hospitalized for COVID-19 in Liberia: who were they, and what were their outcomes? F1000Research 13:656 2024 [PMID: 39564431]
8. Huang X, Wu J, Xu J, Wang H, Chen Z, Fan XY, Hu Z. Mycobacterium tuberculosis Antigen Rv1471 Induces Innate Immune Memory and Adaptive Immunity against Infection The Journal of infectious diseases 2024 [PMID: 39541425]
9. Zhai PY, Chen ZX, Jiang T, Feng J, Zhang B, Zang X, Zhao YL, Qin G. Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 78:101172 2024 [PMID: 39541911]
10. Ferreira Gomes LH, Corrêa PR, Schwarz MGA, Mendonça-Lima L. Functional impact of a deletion in Mycobacterium bovis BCG Moreau celA1 gene Tuberculosis (Edinburgh, Scotland) 149:102576 2024 [PMID: 39546869]
11. Jin P, Liu Q, Chen W, Guo X, Jiang H, Zhang R, Ding M, Zhang K, Cao Z, He J, Jia S, Wei M, Hu Y, Cui L, Wang J, Li Z, Zhang X, Xia X, Wu Y, Zhou L, Zhu Y, Gao C, Zhang T, Zhu F, Zeng G, Zhu L, Li J. Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomized clinical trial Expert review of vaccines 2024 [PMID: 39523878]
12. López-Macías C, Torres M, Armenta-Copca B, Wacher NH, Castro-Castrezana L, Colli-Domínguez AA, Rivera-Hernández T, Torres-Flores A, Damián-Hernández M, Ramírez-Martínez L, la Rosa GP, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Carranza C, Juárez E, Zamudio-Meza H, Carreto-Binaghi LE, Viettri M, Romero-Rodríguez D, Palencia A, Reyna-Rosas E, Márquez-García JE, Sarfati-Mizrahi D, Sun W, Chagoya-Cortés HE, Castro-Peralta F, Palese P, Krammer F, García-Sastre A, Lozano-Dubernard B. Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico Vaccine 43(Pt 2):126511 2024 [PMID: 39527880]
13. Peralta Alvarez MP, Downward K, White A, Harris SA, Satti I, Li S, Morrison A, Sibley L, Sarfas C, Dennis M, Azema HR, Sharpe S, McShane H, Tanner R. Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route Vaccine 42(26):126444 2024 [PMID: 39522337]
14. Han X, Wang X, Han F, Yan H, Sun J, Zhang X, Moog C, Zhang C, Su B. The cGAS-STING pathway in HIV-1 and Mycobacterium tuberculosis coinfection Infection 2024 [PMID: 39509013]
15. Yonezaki S, Shimizu MS, Ota T, Ozasa S, Akabame S, Ide S, Kosai K, Yanagihara K, Ariyoshi K, Furumoto A. Multiple Arterial Aneurysms in a Patient with Spondylitis Following Intravesical Bacillus Calmette-Guérin Administration for Bladder Cancer: A Case Report Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024 [PMID: 39515420]
16. MacPherson P, Stagg HR, Schwalb A, Henderson H, Taylor AE, Burke RM, Rickman HM, Miller C, Houben RMGJ, Dodd PJ, Corbett EL. Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: An epidemiological analysis of historical data PLoS medicine 21(11):e1004448 2024 [PMID: 39499677]
17. Hasso-Agopsowicz M, Hwang A, Hollm-Delgado MG, Umbelino-Walker I, Karron RA, Rao R, Asante KP, Sheel M, Sparrow E, Giersing B. Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030 EBioMedicine :105424 2024 [PMID: 39500705]
18. Seery S, Schroeder P, Galloway T, Abernethy D, Hewinson G. Bovine tuberculosis trends in Wales between 2010 and 2021 The Veterinary record 195(9):e4600 2024 [PMID: 39484938]
19. Yue L, Ma T, Dai Y, Du W, Wang G, Wu L. [Bioinformatics analysis of pathogenesis-associated protein Rv2387 in Mycobacterium tuberculosis] Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 40(11):983-989 2024 [PMID: 39566524]
20. Blanco FC, Vázquez CL, García EA, Rocha RV, Klepp LI, Bigi F. Mycobacterium bovis mutant in the virulence factors PhoP, ESAT-6 and CFP-10 persisted in mouse organs after a year post-vaccination Tuberculosis (Edinburgh, Scotland) 149:102574 2024 [PMID: 39509845]
21. Imazio M, Sukmarova ZN, Nasonov EL. [Complex Issues in the Management of Pericarditis. In Anticipation of the Release of Updated Recommendations of the European Society of Cardiology] Kardiologiia 64(10):57-61 2024 [PMID: 39526519]
22. Mahase E. Tuberculosis: How close are we to a new vaccine? BMJ (Clinical research ed.) 387:q2410 2024 [PMID: 39481867]
23. Wang S, Myers AJ, Irvine EB, Wang C, Maiello P, Rodgers MA, Tomko J, Kracinovsky K, Borish HJ, Chao MC, Mugahid D, Darrah PA, Seder RA, Roederer M, Scanga CA, Lin PL, Alter G, Fortune SM, Flynn JL, Lauffenburger DA. Markov Field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques bioRxiv : the preprint server for biology 2024 [PMID: 39554028]
24. Stefan K, Gordon R, Rolig A, Honkala A, Tailor D, Davis LE, Modi RI, Joshipura M, Khamar B, Malhotra SV. Mycobacterium w - a promising immunotherapeutic intervention for diseases Frontiers in immunology 15:1450118 2024 [PMID: 39534596]
25. Wang S, Myers AJ, Irvine EB, Wang C, Maiello P, Rodgers MA, Tomko J, Kracinovsky K, Borish HJ, Chao MC, Mugahid D, Darrah PA, Seder RA, Roederer M, Scanga CA, Lin PL, Alter G, Fortune SM, Flynn JL, Lauffenburger DA. Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques Cell systems 2024 [PMID: 39504969]
26. Alvarez-Arguedas S, Mazhar K, Wangzhou A, Sankaranarayanan I, Gaona G, Lafin JT, Mitchell RB, Price TJ, Shiloh MU. Single cell transcriptional analysis of human adenoids identifies molecular features of airway microfold cells bioRxiv : the preprint server for biology 2024 [PMID: 39484391]
27. Chin KL, Anibarro L, Chang ZY, Palasuberniam P, Mustapha ZA, Sarmiento ME, Acosta A. Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities Current research in microbial sciences 7:100295 2024 [PMID: 39512261]
28. Dangor Z, Birkhead M, Verwey C, Gray D, Vanker A, Githinji L, Goga A, Masekela R, Zampoli M. Primary ciliary dyskinesia: Meeting the challenges of diagnosis in South Africa South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(8):e2269 2024 [PMID: 39508191]
29. Mortaz E, Dalil Roofchayee N, Jamaati H, Varaham M, Abtahian Z, Afshar B, Rekabi M, Adcock IM, Tabarsi P. Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review Iranian journal of allergy, asthma, and immunology 23(4):457-466 2024 [PMID: 39549298]
30. Ssetaala A, Welsh S, Nakaweesa T, Wambuzi M, Nanyonjo G, Nanvubya A, Mpendo J, Nalutaaya A, Ssempiira J, Nielsen L, Fast P, Price M, Kiwanuka N. Healthcare use and sexually transmitted infections treatment-seeking: a mixed methods cross-sectional survey among hard-to-reach fishing communities of Lake Victoria, Uganda The Pan African medical journal 48:134 2024 [PMID: 39554263]
31. Dymov A M, Lee Yu A, Korchagin M P, Dzharimok A R, Vinarov A Z, Gazimiev M A. [BCG-therapy for non-muscle-invasive bladder cancer: overview of the current trends] Urologiia (Moscow, Russia : 1999) (2):116-120 2024 [PMID: 39563550]
32. Felgueres MJ, Esteso G, Aguiló N, Valés-Gómez M. Selective expansion of anti-tumor innate lymphocytes in long-term cultures after a single BCG pulse Methods in cell biology 190:203-221 2024 [PMID: 39515880]

Nipah virus

1. Chan XHS, Haeusler IL, Choy BJK, Hassan MZ, Takata J, Hurst TP, Jones LM, Loganathan S, Harriss E, Dunning J, Tarning J, Carroll MW, Horby PW, Olliaro PL. Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials The Lancet. Microbe :101002 2024 [PMID: 39549708]
2. Masum MHU, Mahdeen AA, Barua L, Parvin R, Heema HP, Ferdous J. Developing a chimeric multiepitope vaccine against Nipah virus (NiV) through immunoinformatics, molecular docking and dynamic simulation approaches Microbial pathogenesis 197:107098 2024 [PMID: 39521154]

Plasmodium falciparum (Malaria)

1. Elhassan Taha MM, Abdelwahab SI, Moni SS, Farasani A, Aljahdali IA, Oraibi B, Alfaifi HA, Alzahrani AH, Ali Jerah A. Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research Human vaccines & immunotherapeutics 20(1):2427464 2024 [PMID: 39539151]
2. Lamers OAC, Franke-Fayard BMD, Koopman JPR, Roozen GVT, Janse JJ, Chevalley-Maurel SC, Geurten FJA, de Bes-Roeleveld HM, Iliopoulou E, Colstrup E, Wessels E, van Gemert GJ, van de Vegte-Bolmer M, Graumans W, Stoter TR, Mordmüller BG, Houlder EL, Bousema T, Murugan R, McCall MBB, Janse CJ, Roestenberg M. Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite The New England journal of medicine 391(20):1913-1923 2024 [PMID: 39565990]
3. Kudiabor H. This malaria vaccine is delivered by a mosquito bite Nature 2024 [PMID: 39567825]
4. Reyes RA, Raghavan SSR, Hurlburt NK, Introini V, Bol S, Kana IH, Jensen RW, Martinez-Scholze E, Gestal-Mato M, López-Gutiérrez B, Sanz S, Bancells C, Fernández-Quintero ML, Loeffler JR, Ferguson JA, Lee WH, Martin GM, Theander TG, Lusingu JPA, Minja DTR, Ssewanyana I, Feeney ME, Greenhouse B, Ward AB, Bernabeu M, Pancera M, Turner L, Bunnik EM, Lavstsen T. Broadly inhibitory antibodies to severe malaria virulence proteins Nature 2024 [PMID: 39567685]
5. Lee C, Ünlü ES, White NFD, Almagro-Garcia J, Ariani C, Pearson RD. Pf-HaploAtlas: an interactive web app for spatiotemporal analysis of P. falciparum genes Bioinformatics (Oxford, England) 2024 [PMID: 39565917]
6. Boonyakida J, Nakayama K, Kusakisako K, Ikadai H, Park EY. Modular Display of Plasmodium yoelii Circumsporozoite Surface Protein and Merozoite Surface Protein-1 on Norovirus-like Particles Bioconjugate chemistry 2024 [PMID: 39564748]
7. Faria ACM, Fock RA, Soares IS, Silveira ELV. Protein-energetic malnutrition hinders malaria vaccine-derived cellular and class-switched antibody responses against the Plasmodium vivax circumsporozoite protein in mice European journal of clinical nutrition 2024 [PMID: 39562824]
8. Chaikitgosiyakul S, Kuamsab N, Tia T, Putaporntip C, Jongwutiwes S. Transcription and Copy Number Variation of Plasmodium falciparum var2csa among Nonpregnant Malaria Patients in Thailand The American journal of tropical medicine and hygiene 2024 [PMID: 39561405]
9. Krenger PS, Roques M, Vogt AS, Pardini A, Rothen DA, Balke I, Schnider ST, Mohsen MO, Heussler VT, Zeltins A, Bachmann MF. Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development NPJ vaccines 9(1):225 2024 [PMID: 39557901]
10. Gulati GK, Simpson AC, MacMillen Z, Krieger K, Sharma S, Erasmus JH, Reed SG, Davie JW, Avril M, Khandhar AP. Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability Journal of controlled release : official journal of the Controlled Release Society 377:81-92 2024 [PMID: 39547422]
11. Mao J, Kang HJ, Eom GD, Yoon KW, Chu KB, Quan FS. Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2 Vaccine 43(Pt 2):126530 2024 [PMID: 39551038]
12. Yoon KW, Chu KB, Eom GD, Mao J, Heo SI, Quan FS. Dose sparing enabled by immunization with influenza vaccine using orally dissolving film International journal of pharmaceutics 667(Pt B):124945 2024 [PMID: 39550013]
13. Nappi TJ, Butler NS. Tragedy of the commons: the resource struggle during Plasmodium infection Trends in parasitology 2024 [PMID: 39547909]
14. Mwesigwa A, Ocan M, Cummings B, Musinguzi B, Kiyaga S, Kiwuwa SM, Okoboi S, Castelnuovo B, Bikaitwoha EM, Kalyango JN, Karamagi C, Nankabirwa JI, Nsobya SL, Byakika-Kibwika P. Plasmodium falciparum genetic diversity and multiplicity of infection among asymptomatic and symptomatic malaria-infected individuals in Uganda Tropical medicine and health 52(1):86 2024 [PMID: 39543779]
15. Hirasawa Y, Kasagi C, Koyama E, Myojin H, Tougan T, Horii T, Uchiyama N, Kaneda T, Morita H. Cathagines A-D, new bisindole alkaloids from Catharanthus roseus Journal of natural medicines 2024 [PMID: 39540962]
16. Tapaopong P, Chainarin S, Mala A, Rannarong A, Kangkasikorn N, Kusolsuk T, Roobsoong W, Cui L, Nguitragool W, Sattabongkot J, Bantuchai S. Declining genetic polymorphism of the C-terminus Merozoite Surface Protein-1 amidst increased Plasmodium knowlesi transmission in Thailand Malaria journal 23(1):342 2024 [PMID: 39538241]
17. Chou RT, Ouattara A, Takala-Harrison S, Cummings MP. Plasmodium vivax antigen candidate prediction improves with the addition of Plasmodium falciparum data NPJ systems biology and applications 10(1):133 2024 [PMID: 39537634]
18. Traore K, Thera A, Coulibaly D, Koné AK, Guindo B, Tangara B, Diawara AA, Travassos MA, Thera MA. A Qualitative Method To Assess a History of Cerebral Malaria in Malian Children The American journal of tropical medicine and hygiene 2024 [PMID: 39531723]
19. Jacobs-Lorena M, Cha SJ. Unbiased phage display screening identifies hidden malaria vaccine targets Emerging microbes & infections :2429617 2024 [PMID: 39529575]
20. Soares IF, de Oliveira Baptista B, da Silva Matos A, Rodrigues-da-Silva RN, Kujbida Junior MA, Albrecht L, Rodolphi CM, Scopel KKG, Alencar ALC, de Souza RM, Dos Santos de Souza HA, Riccio EKP, de Barros JP, Totino PRR, Daniel-Ribeiro CT, Pratt-Riccio LR, Lima-Junior JDC. Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities Scientific reports 14(1):27343 2024 [PMID: 39521783]
21. Shaikh R, Kanjaksha G, Gorakshakar A. Duffy Binding Protein Ligand (PvDBP) gene duplication in Indian P. Vivax Malaria isolates: implication for malaria research Current genetics 70(1):18 2024 [PMID: 39520514]
22. Wafula ST, Maiga-Ascofare O, Struck NS, Mathanga DP, Cohee LM, May J, Puradiredja DI, Lorenz E. Socioeconomic disparities in Plasmodium falciparum infection risk in Southern Malawi: mediation analyses Scientific reports 14(1):27290 2024 [PMID: 39516554]
23. Patel PN, Tolia NH. RH5 antigenic landscape shapes vaccine and antibody development Trends in pharmacological sciences 2024 [PMID: 39510863]
24. Aggrey S, Egeru A, Kalule JB, Lukwa AT, Mutai N, Hartnack S. Household satisfaction with health services and response strategies to malaria in mountain communities of Uganda Transactions of the Royal Society of Tropical Medicine and Hygiene 2024 [PMID: 39492781]
25. Eneh S, Onukansi F, Ikhuoria O, Ojo T. Designing and deploying caller tunes on mobile phones to promote malaria vaccine uptake in Africa: can the technology acceptance model (TAM) help? Malaria journal 23(1):325 2024 [PMID: 39488704]
26. Plieskatt J, Ofori EA, Naghizadeh M, Miura K, Flores-Garcia Y, Borbye-Lorenzen N, Tiono AB, Skogstrand K, Sagara I, Zavala F, Theisen M. ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults Frontiers in immunology 15:1481829 2024 [PMID: 39555079]
27. Obeagu EI, Obeagu GU. Emerging public health strategies in malaria control: innovations and implications Annals of medicine and surgery (2012) 86(11):6576-6584 2024 [PMID: 39525724]
28. Mukhiya R, Fleischmann WA, Loughland JR, Chan JA, de Labastida Rivera F, Andrew D, Beeson JG, McCarthy JS, Barber BE, Lopez JA, Engwerda C, Thomson-Luque R, Boyle MJ. Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection EBioMedicine 109:105419 2024 [PMID: 39490199]
29. Saleh BH, Lugaajju A, Tijani MK, Danielsson L, Morris U, Persson KEM. An immuno-inflammatory profiling of asymptomatic individuals in a malaria endemic area in Uganda Acta tropica 260:107446 2024 [PMID: 39488329]
30. Zacharia MM, Ziema SA, Abanga WA, Kyeremeh RA, Tamal CS, Adjei MR, Kubio C. RTS, S malaria vaccination among children aged 24-59 months in the Sunyani Municipality, Ghana; 2023 Vaccine 42(26):126490 2024 [PMID: 39486354]
31. Salkeld J, Duncan A, Minassian AM. Malaria: Past, present and future Clinical medicine (London, England) 24(6):100258 2024 [PMID: 39490741]
32. Chutiyami M. Recent Trends in Malaria Vaccine Research Globally: A Bibliometric Analysis From 2005 to 2022 Journal of parasitology research 2024:8201097 2024 [PMID: 39483206]
33. Gonçalves AF, Lima-Pinheiro A, Ferreira PE. Ubiquitin-proteasome system in Plasmodium: a potential antimalarial target to overcome resistance - a systematic review Frontiers in medicine 11:1441352 2024 [PMID: 39497850]
34. Ba A, Thiam LG, Pouye MN, Guo Y, Patel SD, Sene SD, Diallo F, Li R, Cisse A, Guerra N, Laqqa S, Mangou K, Moore AJ, Sadio BD, Ndiaye JLA, Mbengue A, Sheng Z, Shapiro L, Bei AK. Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in Senegal medRxiv : the preprint server for health sciences 2024 [PMID: 39484257]
35. Prazeres F. Letter to the editor: Evaluating ChatGPT as a tool for educating caregivers on malaria vaccination for children Clinical and experimental vaccine research 13(4):370-371 2024 [PMID: 39525671]
36. Kleinhans I, Mahanjana S, Els F, Mabona M, Pitso LA, Malatje G, Kok G, Raman J. The prevalence and distribution of malaria in Mpumalanga Province before and during COVID-19 (2017 - 2022) South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(8):e1736 2024 [PMID: 39508196]
37. Bevela JY, Billong S, Njankouo YM, Kenko I, Bonsou G. [Morbidity and mortality in hospitalised patients vaccinated versus hospitalised patients not vaccinated against COVID-19 in three regions of Cameroon] The Pan African medical journal 48:114 2024 [PMID: 39545032]

Salmonella

1. Zafarmand-Samarin M, Nazarian S, Aghaie SM, Sadeghi D, Samiei-Abianeh H, Felegary A. Therapeutic efficacy of SipD/LptD-specific IgY entrapped in alginate nanoparticles against Salmonella Typhimurium infection Heliyon 10(21):e39650 2024 [PMID: 39524789]
2. Park JY, Senevirathne A, Lee JH. Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice Vaccine 43(Pt 1):126524 2024 [PMID: 39547019]
3. Izumiya H, Chiou C-S, Morita M, Sato T, Noguchi A, Harada T, Akeda Y, Ohnishi M. Genomic characteristics of Salmonella enterica serovar Blockley Microbiology spectrum :e0204824 2024 [PMID: 39540775]
4. Pan J, Wei RR, Xu P, Liu YY, Li C, Ding GW, Fan J, Li YH, Yu JY, Dai P. Progress in the application of Salmonella vaccines in poultry: A mini review Veterinary immunology and immunopathology 278:110855 2024 [PMID: 39561520]
5. Carducci M, Massai L, Lari E, Semplici B, Grappi S, Maria N, Jones E, Conti V, Piu P, Scorza FB, Iturriza-Gómara M, Montomoli E, Pollard AJ, Rondini S, Rossi O. Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against S. Paratyphi A in human samples Frontiers in immunology 15:1443137 2024 [PMID: 39539546]
6. Di Benedetto R, Massai L, Wright M, Mancini F, Cleveland M, Rossi O, Giannelli C, Berlanda Scorza F, Micoli F. Adjuvanted Modified Bacterial Antigens for Single-Dose Vaccines International journal of molecular sciences 25(21) 2024 [PMID: 39519015]
7. Stupak A, Kwiatek M, Gęca T, Kwaśniewska A, Mlak R, Nawrot R, Goździcka-Józefiak A, Kwaśniewski W. A Virome and Proteomic Analysis of Placental Microbiota in Pregnancies with and without Fetal Growth Restriction Cells 13(21) 2024 [PMID: 39513860]
8. Bian X, Liu Q, Chen Y, Zhang W, Li M, Zhang X, Yang L, Liao Y, Kong Q. Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice Gut microbes 16(1):2424983 2024 [PMID: 39529227]
9. Kavai SM, Oyugi J, Mbae C, Wairimu C, Kering K, Kebenei C, Muturi P, Omulo S, Kariuki S. Genotypic Diversity among Salmonella Typhi Isolated from Children Living in Informal Settlements in Nairobi, Kenya International journal of clinical microbiology 1(3):18-27 2024 [PMID: 39483419]

Shigella

1. . Correction to: Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study The Journal of infectious diseases 2024 [PMID: 39566030]
2. Afrad MH, Islam MT, Begum YA, Saifullah M, Ahmmed F, Khan ZH, Habib ZH, Alam AN, Shirin T, Bhuiyan TR, Ryan ET, Khan AI, Qadri F. Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014-2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases Microbiology spectrum :e0073924 2024 [PMID: 39540737]
3. Jones A, Ahmed SM, Platts-Mills JA, Kotloff KL, Levine AC, Nelson EJ, Pavia AT, Khan AI, Leung DT. Etiology of Severely Dehydrating Diarrheal Illness in Infants and Young Children Residing in Low- and Middle-Income Countries Open forum infectious diseases 11(11):ofae619 2024 [PMID: 39494449]
4. Akhgar S, Noorpisheh Ghadimi S, Farhani I, Ghasemian A, Mahmoodi S, Mardkhoshnood M, Zarenezhad A. Immunization of BALB/c Mice against Shigella sonnei Using a Multiepitope Protein Vaccine through Intranasal and Subcutaneous Administration Iranian journal of allergy, asthma, and immunology 23(4):412-421 2024 [PMID: 39549294]
5. Lu T, Ericsson AC, Dietz ZK, Cato AK, Coghill LM, Picking WD, Picking WL. Impact of an intranasal L-DBF vaccine on the gut microbiota in young and elderly mice Gut microbes 16(1):2426619 2024 [PMID: 39520707]

Variola major (Smallpox)

1. Duffy J, Yih WK, Walton K, DeSilva MB, Glanz JM, Hambidge SJ, Jackson LA, Klein NP, Lewin BJ, Naleway AL, Sundaram ME, Maro JC, Weintraub E. JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States Infection 2024 [PMID: 39565485]
2. Trefry SV, Awasthi M, Raney CN, Cregger AL, Gonzales CA, Layton BL, Enamorado RN, Martinez NA, Gohegan DS, Masoud-Bahnamiri M, Cho JY, Myscofski DM, Moulaei T, Ziółkowska NE, Goebel SJ, Lederman S, Bavari S, Nasar F. Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models mSphere :e0026524 2024 [PMID: 39535212]
3. Radaelli A, Zanotto C, Brambilla C, Adami T, Paolini F, Venuti A, Manuka A, Mehmeti I, De Giuli Morghen C. Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses Virology journal 21(1):282 2024 [PMID: 39511612]
4. Rizk Y, Lippi G, Henry BM, Notarte KI, Rizk JG. Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes Drugs 2024 [PMID: 39497022]
5. Silva RMA, Kobayashi CD, Martins AF, Araújo ACM, Andrade PHS, Nóbrega MEBD, Cabral CM, Moraes MB, Cardoso FD, Victer TNDF, Krummenauer A, Soares ROPS, Fernandes EG, Percio J. [Descriptive study of events allegedly attributable to mpox vaccination in Brazil in 2023] Cadernos de saude publica 40(10):e00006624 2024 [PMID: 39504058]
6. Gutiérrez-Chablé LE, Ochoa-Fuentes DA, Lezama-Ávila FI, García-Flores MA, Santos-López G, Méndez-Martínez S. [Mpox in humans: an overview of the 2022-2023 epidemic] Revista medica del Instituto Mexicano del Seguro Social 62(2):1-9 2024 [PMID: 39514866]

Vibrio cholerae

1. Singh B, Kodgire P. Refolding dynamics and immunoinformatic insights into Vibrio cholerae OmpA, OmpK, and OmpV for vaccine applications International journal of biological macromolecules 283(Pt 2):137643 2024 [PMID: 39547634]
2. Jones A, Ahmed SM, Platts-Mills JA, Kotloff KL, Levine AC, Nelson EJ, Pavia AT, Khan AI, Leung DT. Etiology of Severely Dehydrating Diarrheal Illness in Infants and Young Children Residing in Low- and Middle-Income Countries Open forum infectious diseases 11(11):ofae619 2024 [PMID: 39494449]

Yersinia pestis (Plague)

1. Yang YF, Lin YJ, You SH, Lu TH, Chen CY, Wang WM, Ling MP, Chen SC, Liao CM. A Regional-Scale Assessment-Based SARS-CoV-2 Variants Control Modeling with Implications for Infection Risk Characterization Infection and drug resistance 17:4791-4805 2024 [PMID: 39498414]

---

Click HERE to see the publications in the last month.